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The prevalence of allergic diseases and asthma in childhood has been inc-
reased during the last decades and several environmental factors operating 
during early childhood or even before birth are suggested to play a role. The 
present register-based study investigated whether maternal sociodemo-
graphic factors, perinatal factors and maternal and child’s use of antibiotics 
are associated with the risk of cow’s milk allergy and asthma in childhood. 
The main findings of the present study include that the use of antibiotics by 
the mother and the child were associated with an increased risk of both cow’s 
milk allergy and asthma. Further, although several maternal sociodemographic 
background and perinatal factors were found to be associated with either the 
risk of cow’s milk allergy or asthma, only a high number of maternal previous 
deliveries was associated with a decreased risk of both cow’s milk allergy and 
asthma. The evidence from the present study emphasise the important and 
complex role of prenatal and early childhood exposures in the development of 
cow’s milk allergy and asthma in childhood.
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Abstract 
Johanna Metsälä. Maternal and perinatal characteristics, use of antibiotics and the 
risk of cow's milk allergy and asthma in childhood. National Institute for Health 
and Welfare (THL). Research 125. 87 pages. Helsinki, Finland 2014. 
ISBN 978-952-302-137-2 (printed); ISBN 978-952-302-138-9 (pdf) 
 
 
The prevalence of asthma and allergic diseases in childhood has increased in sev-
eral industrialized countries since the second half of the twentieth century. In some 
countries, the prevalence is still rising, although in others it seems to have plat-
eaued or even decreased. It has been suggested that environmental factors operat-
ing prenatally and in early life affect the development of asthma and allergic dis-
eases. Particularly changes in microbial exposure are proposed to play an im-
portant role in the development and maturation of the immune system. Thus, the 
factors that affect microbial exposure, such as mode of delivery and the use of 
antibiotics, may influence the development of asthma and allergic diseases. Sever-
al studies have explored the associations between perinatal factors and children's 
use of antibiotics and the risk of asthma, with inconsistent findings, while less is 
known about environmental risk factors for cow’s milk allergy. 
The aim of the present study was to assess whether maternal background fac-
tors, perinatal factors and the use of antibiotics are associated with the develop-
ment of cow’s milk allergy and asthma in childhood. These associations were 
addressed in a register-based case-control study nested in a cohort of all Finnish 
children born between 1 January 1996 and 30 April 2004. Among these children, 
all those who were diagnosed with cow’s milk allergy (i.e. received a special re-
imbursement for the cost of special infant formula) or asthma (i.e. received a spe-
cial reimbursement for the cost of antiasthmatic drugs) by the end of year 2005 
and purchased, respectively, special infant formulas or antiasthmatic drugs after 
diagnosis were identified as cases. For each case, one sex-, birth date- and birth 
hospital district-matched control child was selected. Altogether, 16,237 cow’s 
milk allergy case-control pairs and 20,272 asthma case-control pairs were included 
in the study.  
Information on received special reimbursements, drug purchases, maternal 
background and perinatal factors were obtained from, respectively, the Special 
Reimbursement Register of the Social Insurance Institution, the Drug Prescription 
Register of the Social Insurance Institution and the Finnish Medical Birth Register 
of the National Institute for Health and Welfare. Statistical analysis was conducted 
using conditional logistic regression separately for children diagnosed with asthma 
before the age of three years and at the age of three years or later, as the asthma 
diagnosis in young children is challenging. Thus, the results related to cow’s milk 
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allergy and asthma diagnosed at the age of three years or later are considered as 
the main results of the present study. 
The number of maternal previous deliveries was inversely associated with the 
risk of both cow’s milk allergy (OR 0.71, 95% CI 0.59–0.86 for five or more de-
liveries vs. no previous deliveries) and asthma diagnosed at the age of three years 
or later (OR 0.36, 95% CI 0.27–0.49 for five or more deliveries vs. no previous 
deliveries). In addition, maternal age at delivery, socioeconomic status, child’s 
birth weight and delivery by caesarean section were directly associated with the 
risk of cow’s milk allergy. Maternal smoking during pregnancy and multiple 
pregnancy were associated with a decreased risk of cow’s milk allergy. Further, 
maternal asthma and a short gestational age were associated with an increased risk 
of asthma diagnosed at the age of three years or later.  
Maternal use of antibiotics during pregnancy was associated with an increased 
risk of cow’s milk allergy (OR 1.21, 95% CI 1.14–1.28) and asthma diagnosed at 
the age of three years or later (OR 1.14, 95% CI 1.04–1.24) in the offspring after 
considering several maternal sociodemographic background and perinatal factors 
and the child’s use of antibiotics. Maternal use of cephalosporins during pregnan-
cy was associated with the risk of both cow’s milk allergy and asthma diagnosed 
at the age of three years or later. In addition, maternal use of macrolides and peni-
cillins with extended spectrum were associated with the risk of cow’s milk allergy.  
The children’s own use of antibiotics during early childhood was associated 
with an increased risk of cow’s milk allergy (OR 1.71, 95% CI 1.59–1.84) and 
asthma diagnosed at the age of three years or later (OR 1.55, 95% CI 1.44–1.67). 
All common specific antibiotics used during early childhood were associated with 
the risk of both cow’s milk allergy and asthma diagnosed at the age of three years 
or later, except phenoxymethylpenicillin, which was not associated with the risk of 
asthma.  
In summary, the present study found that the use of antibiotics by the mother 
and the child were associated with an increased risk of both cow’s milk allergy 
and asthma diagnosed at the age of three years or later in childhood. Further, alt-
hough several maternal sociodemographic background and perinatal factors were 
found to be associated with either the risk of cow’s milk allergy or asthma in 
childhood, only a high number of maternal previous deliveries were associated 
with a decreased risk of both cow’s milk allergy and asthma diagnosed at the age 
of three years or later. The antibiotics and asthma findings are in line with results 
from similar large, register-based studies, but the cow’s milk allergy findings will 
have to be confirmed in future studies. In addition, biological mechanisms under-
pinning the associations observed in the present study need to be explored further.  
The results of the present study provide further evidence that environmental 
factors affecting microbial exposure during the prenatal period and in early child-
hood may play a role in the development of cow’s milk allergy and asthma in 
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childhood, although some maternal-related and perinatal risk factors seem to be 
different for these two diseases.  
 
Keywords: antibiotics, asthma, cow’s milk allergy, children, epidemiology, peri-
natal factors, registries 
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Tiivistelmä 
Johanna Metsälä. Äidin tausta- ja perinataalitekijöiden sekä antibioottien käytön 
yhteys lapsen maitoallergiaan ja astmaan. Terveyden ja hyvinvoinnin laitos 
(THL). Tutkimus 125. 87 sivua. Helsinki, Finland 2014. 
ISBN 978-952-302-137-2 (painettu); ISBN 978-952-302-138-9 (pdf) 
 
Lapsuusiän astman ja allergisten sairauksien esiintyvyys on noussut useissa länsi-
maissa 1900-luvun puolivälin jälkeen. Esiintyvyys nousee yhä joissakin maissa, 
vaikka toisissa maissa nousu näyttäisi pysähtyneen tai jopa laskeneen. Varhaislap-
suuden ja jopa sikiöaikaisten ympäristötekijöiden arvellaan olevan yhteydessä 
astman ja allergisten sairauksien syntyyn. Erityisesti muuttuneella mikrobialtistuk-
sella ja suoliston mikrobistolla on mahdollisesti keskeinen vaikutus immunipuo-
lustuksen kehittymiseen ja kypsymiseen. Siten niillä tekijöillä, joilla on vaikutusta 
mikrobialtistukseen ja suoliston mikrobistoon, kuten synnytystavalla ja antibioot-
tien käytöllä, saattaa olla merkitystä astman ja allergisten sairauksien kehittymi-
sessä. Perinataalitekijöiden ja lapsen antibioottien käytön yhteyttä astman syntyyn 
on selvitetty useissa tutkimuksissa, kun taas eri ympäristötekijöiden yhteyttä leh-
mänmaitoallergian syntyyn on tutkittu vain vähän. 
Tämän tutkimuksen tavoitteena oli selvittää äidin taustatekijöiden, perinataali-
tekijöiden ja antibioottien käytön yhteyttä lapsen riskiin sairastua lehmänmaitoal-
lergiaan ja astmaan. Näitä yhteyksiä selvitettiin rekisteritietoihin pohjautuvassa 
upotetussa tapaus-verrokki asetelmassa. Tutkittavat oli poimittu kaikista Suomessa 
1.1.1996–30.4.2004 syntyneistä lapsista. Näistä lapsista kaikki ne, joille oli myön-
netty erityisäidinmaidonkorvikkeiden tai lääkkeiden erityiskorvausoikeus leh-
mänmaitoallergian tai astman johdosta vuoden 2005 loppuun mennessä ja jotka 
olivat ostaneet erityisäidinmaidonkorvikkeita tai astmalääkkeitä diagnoosin (eri-
tyiskorvausoikeuden) jälkeen määriteltiin tapauksiksi. Jokaiselle tapaukselle poi-
mittiin sukupuolen, syntymäajan ja syntymäsairaanhoitopiirin mukaan kaltaistettu 
verrokki. Tutkimukseen otettiin lopulta mukaan 16237 maitoallergian ja 20272 
astman tapaus-verrokkiparia. Erityiskorvausoikeus- ja lääkeostotiedot saatiin Kan-
saneläkelaitoksen lääketiedostoista ja tiedot äidin taustatekijöistä ja perinataalite-
kijöistä saatiin Terveyden ja hyvinvoinnin laitoksen ylläpitämästä Syntyneiden 
lasten rekisteristä. Tilastolliset analyysit toteutettiin käyttäen ehdollista logistista 
regressiota. Analyysit tehtiin erikseen alle 3-vuotiaina ja 3-vuotiaana tai sitä van-
hempana diagnoosin saaneilla lapsilla, sillä astma-diagnoosi on haastellinen pieni-
lä lapsilla. Siten tämän työn päätuloksiksi voidaan katsoa tulokset maitoallergian 
ja astma-diagnoosin 3-vuotiaana tai sitä vanhempana saaneiden osalta. 
Äidin aikaisempien synnytysten määrä oli käänteisessä yhteydessä sekä leh-
mänmaitoallergian (OR 0.71, 95% CI 0.59–0.86, 5 tai useampi synnytys vs. ei 
aikaisempia synnytyksiä) että 3-vuotiaana tai sitä vanhempana diagnosoidun ast-
man (OR 0.36, 95% CI 0.27–0.49, 5 tai useampi synnytys vs. ei aikaisempia syn-
 
 
THL — Research 125 • 2014 11 Perinatal factors, antibiotics and childhood allergies 
 
nytyksiä) riskiin. Lisäksi, äidin ikä ja sosioekonominen asema synnytyksen hetkel-
lä sekä lapsen syntymäpaino ja syntyminen keisarinleikkauksella olivat suorassa 
yhteydessä lehmänmaitoallergian riskiin. Äidin tupakointi raskauden aikana ja 
monisikiöraskaus olivat yhteydessä vähentyneeseen lehmänmaitoallergian riskiin. 
Lyhyt raskauden kesto oli yhteydessä suurentuneeseen 3-vuotiaana tai sitä van-
hempana diagnosoidun astman riskiin. 
Äidin raskaudenaikainen antibioottien käyttö oli yhteydessä lapsen suurentu-
neeseen lehmänmaitomaitoallergian (OR 1.21, 95% CI 1.14–1.28) ja 3-vuotiaana 
tai sitä vanhempana diagnosoidun astman  (OR 1.14, 95% CI 1.04–1.24) riskiin, 
kun oli huomioitu useita äidin taustatekijöitä, perinataalitekijöitä ja lapsen oma 
antibioottien käyttö. Äidin raskauden aikana käyttämät kefalosporiinit olivat yh-
teydessä lapsen suurentuneeseen lehmänmaitoallergian ja astman riskiin. Lisäksi 
äidin käyttämät makrolidit ja laajakirjoiset penisilliinit olivat yhteydessä suurentu-
neeseen lehmänmaitoallergian riskiin.  
Lapsen oma antibioottien käyttö varhaislapsuudessa oli yhteydessä suurentu-
neeseen lehmänmaitoallergian (OR 1.71, 95% CI 1.59–1.84) ja 3-vuotiaana tai sitä 
vanhempana diagnosoidun astman (OR 1.55, 95% CI 1.44–1.67) riskiin. Kaikki 
yleisesti lapsilla käytetyt antibiootit, paitsi fenoksimetyylipenislliini astman osalta, 
olivat yhteydessä sekä lehmänmaitoallergian että astman suurentuneeseen riskiin.  
Sekä äidin että lapsen antibioottien käyttö oli yhteydessä suurentuneeseen leh-
mänmaitoallergian ja 3-vuotiaana tai sitä vanhempana diagnosoidun astman ris-
kiin. Lisäksi, vaikka useat äidin taustatekijät ja perinataalitekijät olivat yhteydessä 
lapsen riskiin sairastua joko lehmänmaitoallergiaan tai astmaan, vain äidin aikai-
sempien synnytysten lukumäärä oli käänteisessä yhteydessä sekä lehmänmaitoal-
lergian että 3-vuotiaana tai sitä vanhempana diagnosoidun astman riskiin. Antibi-
oottien käyttöön ja astmariskiin liittyvät havainnot ovat samansuuntaisia kuin mitä 
on aikaisemmin havaittu muissa vastaavissa, isoissa rekisteritietoihin perustuvissa 
tutkimuksissa, kun taas lehmänmaitoallergiaan liittyvät havainnot tulee vahvistaa 
lisätutkimuksin. Lisäksi, tässä tutkimuksessa havaittujen yhteyksien taustalla ole-
vista biologisista mekanismeistä tarvitaan lisää tutkimuksia. Tämän tutkimuksen 
tulokset tukevat käsitystä siitä, että sikiöaikaisilla ja varhaislapsuuden mikrobial-
tistukseen yhteydessä olevillä ympäristötekijöillä on mahdollisesti vaikutusta leh-
mänmaitoallergian ja astman kehittymiseen lapsuusiässä, vaikka sairauksien riski-
tekijät näyttävät osittain eroavan. 
 
Avainsanat: antibiootit, astma, epidemiologia, lapset, lehmänmaitoallergia, pe-
rinataalitekijät, rekisterit 
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1 Introduction  
Cow’s milk allergy (CMA) is a common food allergy in early childhood and 
asthma one of the most common chronic conditions in childhood. In Finland, a 
cumulative incidence of 1.9% of challenge-confirmed CMA among infants less 
than 12 months of age (Saarinen et al. 1999) and a prevalence of 7% of asthma 
among schoolchildren aged 7 to 16 years has been reported (Hugg et al. 2008). No 
reliable data on time trends in the occurrence of CMA have been published, but 
the prevalence of asthma and allergic diseases like allergic rhinitis in childhood 
has shown an increasing trend in several industrialized countries since the second 
half of the twentieth century (Eder et al. 2006). In some countries, the prevalence 
is still rising, although in other countries the prevalence seems to have plateaued 
or even decreased (Pearce et al. 2007).  
Although the development of asthma and allergic diseases has a strong genetic 
component, the rise in the prevalence of these diseases indicates that environmen-
tal factors play an important role as well. Increasing evidence suggests that im-
portant time periods of these environmental factors to come into play are early life 
or even in utero (Holt and Jones 2000). The original hygiene hypothesis suggested 
that modern healthcare and hygiene practices and reduced exposure to infections 
were linked to the development of allergic diseases (Strachan 1989). Over the 
years, the hygiene hypothesis has been revised and the focus has shifted from 
clinical infections to overall microbial exposure. Accumulating evidence suggests 
that gut microbiota play an important role in the maturation and development of 
the immune system. The “microflora hypothesis” suggests that perturbations in the 
gastrointestinal microbiota as a result of reduced microbial exposure result in im-
mature microbiota, which may delay proper maturation of the immune system, and 
this delay may lead to an increase in asthma and allergic diseases (Noverr and 
Huffnagle 2005). 
The factors that have been suggested to be related to the development of asth-
ma include infections, non-pathogenic microbes, dietary factors and exposure to 
tobacco smoke, air pollutants and allergens (Eder et al. 2006), as well as various 
factors related to pregnancy, delivery and fetal growth (Bernsen et al. 2006). De-
spite active research, evidence on early life factors and the development of asthma 
is not consistent. Further, evidence on the role of environmental factors in the 
development of CMA or any food allergy is limited. Identification of risk and 
protective factors for CMA, asthma and other allergic diseases is important for 
prevention strategies. Although not all early life factors are easily modifiable, 
identification of such factors may help focus preventive strategies on children at 
high risk. Given the widespread use of antibiotics and their potential as a modifia-
Introduction 
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ble exposure, it is important to thoroughly examine the role of antibiotics in the 
development of asthma and allergic diseases.  
The aim of the present study was to assess whether maternal background fac-
tors, perinatal factors and the use of antibiotics are associated with the develop-
ment of cow’s milk allergy and asthma in childhood. 
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2 Review of the literature  
2.1 Definitions, mechanisms and occurrence of cow's milk 
      allergy and asthma 
 
Cow's milk allergy 
According to a revision of the allergy nomenclature, allergy is defined as a hyper-
sensitivity reaction initiated by specific immunologic mechanisms (Johansson et 
al. 2004). Cow's milk allergy (CMA) is defined as an adverse clinical reaction to 
ingested cow's milk proteins based on an immunologically mediated adverse reac-
tion to the provoking proteins at doses which are tolerated by healthy persons 
(World Allergy Organization 2010). Exposure to cow's milk proteins provokes an 
immune response in all infants, although in healthy infants this response is sup-
pressed and oral tolerance is developed. If oral tolerance is not achieved, processes 
ending to a release of inflammatory mediators will be activated, and these inflam-
matory reactions can occur in several organs. Mechanisms of CMA are best un-
derstood and described in antibody-mediated, (immunoglobulin E [IgE]-mediated) 
CMA, while the precise immunologic mechanisms of cell-mediated (non-IgE 
mediated) CMA remain less clear. In IgE-mediated CMA typical symptoms, 
which usually develop rapidly within minutes or an hour after ingestion of cow's 
milk protein, include symptoms in the skin like urticaria and angioedema respira-
tory symptoms like wheeze, and anaphylaxis. In non-IgE-mediated CMA, symp-
toms tend to have later onset, from hour to days after ingestion of cow's milk pro-
tein, and most commonly involve the gastrointestinal tract, although – as in IgE-
mediated CMA – various symptoms are possible. (World Allergy Organization 
2010) 
There is a consensus that the diagnosis of food allergy has to be based on oral 
food challenge procedures that establish a causal relation between the ingestion of 
a particular food and a subsequent clinical reaction (Sampson et al. 2012). Of the 
different challenge procedures, double-blind placebo-controlled food challenge is 
considered the "golden standard" of diagnosing food allergies. However, only a 
minority of studies related to CMA have used this procedure and, in epidemiologi-
cal research, CMA is often defined as either parentally reported or oral food chal-
lenge confirmed CMA (World Allergy Organization 2010). 
During the last ten years, the occurrence of oral food challenge confirmed 
CMA has been evaluated in five birth cohort studies: in Finland, a cumulative 
incidence of 1.9% of challenge confirmed CMA has been reported among infants 
less than 12 months of age. In other birth cohort studies, CMA was challenge con-
Review of the literature 
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firmed in 2.2% of infants in Denmark, Isle of Wight, and Netherlands, as well as 
in 4.9% of infants in Norway (World Allergy Organization 2010). Perception of 
CMA is more common than confirmed CMA; the prevalence of self-reported 
CMA varies between 1% and 17.5% in preschool-aged children and between 1% 
and 13.5% in 5–16-year-old children (World Allergy Organization 2010). No 
reliable data on geographical or time trends on CMA incidence in children have 
been published. 
 
Asthma 
Asthma is defined as a chronic inflammatory disorder associated with variable 
airflow obstruction and bronchial hyperresponsiveness (Papadopoulos et al. 2012). 
A key component in the pathology is chronic inflammation, and various factors 
such as viruses, allergens and exercise can trigger inflammation. These factors 
also induce hyperresponsiveness, and inflammation together with hyperreactivity 
can lead to airway obstruction. Asthma can present with symptoms such as recur-
rent episodes of wheezing, coughing, shortness of breath, and chest tightness (Pa-
padopoulos et al. 2012). In epidemiological research, asthma is often defined 
through information on physician-diagnosed asthma, antiasthmatic drug use, hos-
pitalization due to asthma or asthma symptoms and different classification of these 
symptoms. According to Spycher and co-workers (2010), frequently used asthma 
or wheeze phenotypes are based on 1) triggers/short-term temporal pattern (in-
cluding exclusive viral wheeze and multiple-trigger wheeze), 2) long-term tem-
poral pattern (including early transient wheeze, persistent wheeze and late-onset 
wheeze), 3) presence of allergic sensitization (atopic asthma and non-atopic asth-
ma) or 4) severity (including wheeze and asthma). 
In children, the occurence of recurrent wheezing episodes is a universally ac-
cepted starting point of asthma diagnosis (Papadopoulos et al. 2012). In addition 
to medical history, methods to establish asthma diagnosis include physical exami-
nation, evaluation of lung function, atopy, airway inflammation and bronchial 
hyperresponsiveness and exclusion of alternative diagnoses (Papadopoulos et al. 
2012). In young children, the asthma diagnosis is particularly challenging due to 
difficulties in applying objective lung function measurements. Thus, in infants and 
preschool-aged children, the diagnosis is often based on medical history and 
symptoms.  
In Finland, a 7–8% prevalence of asthma has been reported among school-aged 
children (Hugg et al. 2008, Lai et al. 2009). Further, according to the Finnish So-
cial Insurance Institution’s Special Reimbursement Registry, the number of chil-
dren receiving a special reimbursement for the cost of antiasthmatic medication 
was 1.9 per 100 children in 1994, 3.1 per 100 children in 2002, and 2.6 per 100 
children in 2006 (Mäkelä et al. 2008). The prevalence of asthma symptoms in 
children has been studied at a global level in the International Study on Allergies 
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and Asthma in Childhood conducted in three phases. In Phase III, wide global 
variations in the prevalence of asthma symptoms were observed (Lai et al. 2009). 
Among children aged six to seven years, the global total prevalence of asthma at 
any time was 11.5%, ranging from 3.4% in Africa to 29.2% in Oceania (Lai et al. 
2009). An increasing trend of asthma symptoms has been observed in several 
countries, although the rise seems to have achieved a plateau or even decreased in 
some countries (Pearce et al. 2007). 
2.2 Development of cow’s milk allergy and asthma 
For two decades, the hygiene hypothesis has been one of the leading hypotheses in 
attempts to explain the increasing prevalence of asthma and allergic diseases. The 
hygiene hypothesis was first developed to explain the inverse association between 
number of siblings and hay fever (Strachan 1989). This association was interpret-
ed to mean that shared infections among children within large families attenuate 
the risk of allergy. The hygiene hypothesis stated that modern healthcare and hy-
giene practices and reduced exposure to pathogens would lead to an imbalance of 
the immune system predisposing individuals to the development of allergic dis-
eases (Strachan 1989). Since its inception, several revisions of the hygiene hy-
pothesis have been introduced: the focus in research has shifted from clinical in-
fections to overall microbial exposure and the important role of gut microbiota has 
been recognised (discussed in more detail later). Further, it has been suggested 
that the hygiene hypothesis may be relevant not only for allergic diseases but for 
other immune-mediated diseases such as autoimmune diseases (Bach 2002). Re-
cently, the hygiene hypothesis has been expanded to a biodiversity hypothesis: 
declining biodiversity in the living environment, plants, animals and their habitats, 
is suggested to increase chronic diseases that are associated with inflammation, 
such as asthma and allergic diseases (Von Hertzen et al. 2011).  
According to the Barker hypothesis, restricted fetal growth may reflect insuffi-
cient energy supply for organ development and lead to increased susceptibility to 
coronary heart disease later in life (Barker 1995). This concept of developmental 
origins of cardiovascular diseases and metabolic syndrome has also been dis-
cussed in relation to the development of asthma and allergic diseases (Tedner et 
al. 2012). Asthma has received more research attention than other allergic diseas-
es, and despite active research the mechanisms underpinning the association be-
tween fetal growth and asthma and allergic diseases remains unclear. Whether it is 
the fetal growth restriction, the rapid catch-up growth after birth following re-
stricted fetal growth or some still unknown third factor(s) that predisposes for the 
development of asthma has yet to be determined (Tedner et al. 2012).  
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The role of gut microbiota in the development of asthma and allergic diseases 
The gut microbiota is a major source of microbial exposure, containing an assort-
ment of micro-organisms inhabiting the entire gastrointestinal tract. Colonization 
of the human gut microbiota begins immediately at birth, as upon passage through 
the birth canal infants are exposed to a complex microbial population. After the 
initial establishment of the gut microbiota during the first year of life, the compo-
sition of gut microbiota is host-specific, evolving throughout an individual’s life-
time, and is susceptible to both exogenous and endogenous modifications (Sekirov 
et al. 2010). Stimuli derived from normal gut microbiota have been demonstrated 
in experimental studies to be important in facilitating the development of oral 
tolerance to food allergens (Sudo et al. 1997) and tolerance to inhaled aeroaller-
gens (Noverr and Huffnagle 2005).  
The “microflora hypothesis”, introduced by Noverr and Huffnagle (2005) sug-
gests that perturbations in the gastrointestinal microbiota as a result of reduced 
microbial exposure result in an underdeveloped microbiota. This immature micro-
biota delays proper maturation of the immune system, disrupting the development 
of immunological tolerance and subsequently increasing the development of aller-
gic diseases (Noverr and Huffnagle 2005). The idea of the potential role of gut 
microbiota in the development of allergic diseases has encouraged several obser-
vational studies to assess the association between the gut microbiota composition 
and allergic diseases. Although an association between the gut microbiota compo-
sition and various allergic conditions or symptoms has been reported, no specific 
harmful or protective microbes have been identified yet (Penders et al. 2007). 
Further, there has been a substantial effort to assess the effects of probiotics, living 
micro-organisms that exert health benefits, on the prevention and or treatment of 
allergic diseases in clinical trials. While there is a theoretical basis for probiotics 
having a positive effect in allergy prevention or treatment and some studies have 
shown an association between probiotic supplementation and reduced allergic 
diseases, not all studies have reached the same conclusions (Prescott and Björk-
sten 2007). 
2.3 Factors associated with the development of cow’s milk 
      allergy and asthma 
Despite active research, the causes of asthma and allergic diseases are only partial-
ly understood. Heredity is a generally accepted important risk factor, but the rise 
and international variation in prevalence rates are likely attributable to environ-
mental aspects and gene-environment interactions (Subbarao et al. 2009). Whether 
food allergies and asthma share same genetic and environmental factors or wheth-
er there are some unique factors to each disease is unclear. 
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2.3.1 Genetic factors 
Family history and twin studies have indicated that genetics plays an important 
role in the development of asthma and food allergies (Hong et al. 2009, Subbarao 
et al. 2009). Nearly 100 genes have been found to be associated with asthma or 
asthma-related phenotypes, although not all of these associations could have been 
replicated in further studies (Subbarao et al. 2009). Unlike asthma, only a limited 
number of genetic studies – namely candidate gene association studies – of food 
allergies have been reported (Hong et al. 2009). Polymorphisms in nine genes 
have been associated with food allergy or food allergy severity in at least one 
study, but most of these associations have not been replicated (Hong et al. 2009). 
Some of the genes associated with food allergy are also associated with asthma, 
although the relevance of these genes to both food allergy and asthma together 
remains to unexplored. 
2.3.2 Environmental factors 
The recognition that the priming of the immune system occurs in early childhood 
or even before birth has prompted the idea of a "critical time-window" for envi-
ronmental factors to come to play and impact the development of asthma and al-
lergic diseases (Holt and Jones 2000). Knowledge of the role of different envi-
ronmental factors in the development of CMA or any food allergy remains limited, 
but more extensive research has been conducted on the associations between dif-
ferent environmental factors and the development of asthma in childhood. Those 
factors that have been suggested as being related to changes in the environment 
and thus the development of asthma include infections and other microbes, dietary 
factors, exposure to tobacco smoke, air pollutants and allergens (Eder et al. 2006). 
As the mother is an exclusive environment for the child for the first nine months 
and after birth continues as the closest caregiver, she can be considered as a major 
environmental factor operating in the child's development. Thus, various factors 
related to prenatal period, i.e. pregnancy, and delivery have received growing 
attention (Bernsen et al. 2006). 
 
Infections and non-pathogenic microbes 
Infections in early childhood have been implicated in the development of asthma, 
although their role is complex. For example, severe lower respiratory tract infec-
tions have been associated with an increased risk of asthma (Bartlett et al. 2009), 
while repeated viral infections have been reported to be associated with a de-
creased risk (Illi et al. 2001). Further, indirect measures of infections like the care 
of a child in a daycare centre and high number of older siblings have been shown 
to be associated with both a decreased and an increased risk of asthma (Ball et al. 
2000, McKeever et al. 2001, Hagerhed-Engman et al. 2006). Despite the fact that 
severe lower respiratory tract infections have been linked to later development of 
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asthma, it is still unclear whether these lower respiratory tract infections cause 
subsequent development of asthma or whether these infections merely mark indi-
viduals that have a genetic propensity for developing asthma (Bartlett et al. 2009). 
Further, it has been suggested that qualitative aspects of infections such as timing, 
type and intensity may be crucial in the development of asthma. There is currently 
no evidence that infections would play a major role in the development of cow's 
milk allergy or any food allergy in early childhood. 
Not only pathogenic microbes causing symptomatic infection, but also non-
pathogenic microbes have been suggested as playing a role in the development of 
asthma and allergic diseases. Several studies have shown that exposure to envi-
ronmental microbes is inversely associated with the risk of asthma and allergic 
diseases; for example, a lower prevalence of asthma and atopy has been observed 
in a population with higher number of bacterial exposures compared to a popula-
tion with lower exposure despite these two populations living in geographically 
adjacent areas (Vartiainen et al. 2002). Further, a lower prevalence of asthma and 
allergic diseases among children living on a farm has been found repeatedly, and 
the largest reduction in risk has been demonstrated for those exposed to a farming 
environment both prenatally and postnatally until adulthood (Von Mutius and 
Vercelli 2011). In addition, an observation that microbial diversity of house dust 
was inversely related to the prevalence of childhood asthma independently of 
farming status (Ege et a.l 2011) and that a lower environmental biodiversity in the 
surroundings of study subjects' homes was more common in atopic than in non-
atopic adolescents (Hanski et al. 2012) further emphasizes the role of overall mi-
crobial exposure and environmental biodiversity in the development of asthma and 
allergic diseases. 
 
Diet  
Breast milk, one of the most important early nutritional sources in the postnatal 
period, contains compounds with immodulatory properties, and it has been hy-
pothesized that it protects children from asthma and allergic diseases (Kneepkens 
and Brand 2010). Several studies support the protective role of exclusive breast-
feeding until at least four months of age, but the discussion on the preventive ef-
fects of breastfeeding continues, mainly due to methodological issues (Kneepkens 
and Brand 2010). The role of complementary feeding in the development of aller-
gic diseases has been revised in recent years. Delaying exposure to solid foods or 
avoidance of allergenic foods in infancy is no longer recommended for prevention 
of allergic diseases. In fact, evidence that early introduction of certain foods is 
beneficial in decreasing the risk of asthma and allergic diseases is emerging 
(Nwaru et al. 2013).  
On a nutrient level, it has been hypothesized that changes in antioxidant intake, 
the ratio of dietary n-6:n-3 polyunsaturated fatty acids, and vitamin D may play a 
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role in the development of asthma and allergic diseases (West et al. 2010). Obser-
vational studies have reported inverse associations between asthma and n-3 poly-
unsaturated fatty acids and dietary antioxidants in the postnatal diet, although 
supplementation of infants' diet with fish oil or vitamin D have so far failed to 
show any major benefit (West et al. 2010). A maternal intake of antioxidant rich 
foods, fish oil and vitamin D during pregnancy has been reported to be inversely 
associated with wheezing, asthma and other allergic diseases in the offspring. In 
addition, limited intervention data suggest some benefits of fish oil supplementa-
tion during pregnancy in reducing the risk of allergic disease in offspring. (West et 
al. 2010) 
2.4 Maternal background, perinatal factors and use of anti-
      biotics as risk factors for cow’s milk allergy and asthma 
For the purposes of this review, a literature search from the PubMed and Web of 
Science databases was conducted to find studies that had assessed the association 
between selected maternal background factors and perinatal factors (referring to 
factors operating during pregnancy, delivery and just after pregnancy), as well as 
maternal and child's use of antibiotics and CMA or asthma. Medical Subject Head-
ing (MeSH) search terms “Birth Weight”, “Apgar Score”, “Delivery, Obstetric”, 
“Cesarean Section”, “Pre-Eclampsia”, “Multiple Birth Offspring”,  “Gestational 
Age”, “Fetal Development”, “Premature Birth”, “Birth Order”, “Reproductive 
History”, “Anti-Bacterial Agents”, “Asthma” and the key words wheeze, wheez-
ing, cow’s milk allergy and food allergy were used. Further, reference lists of the 
obtained articles were reviewed. For this review, those observational studies that 
included children or adolescents up to the age of 18 years and were published by 
April 2013 were included (Tables 1–4). Of the studies related to maternal back-
ground and perinatal factors and asthma, only cohort studies published since the 
year 2000 with large sample size (n>1000) were included (Table 2). Of the studies 
related to children's use of antibiotics and asthma or wheeze, only cohort or nested 
case-control studies were included (Table 4). Further, if a study reported results 
for several asthma outcomes, the outcome that was considered most reliable or 
comparable with the present study was included (Tables 1–4). 
2.4.1 Maternal background 
Maternal sociodemographic background and perinatal factors and CMA or other 
food allergies have been explored in 13 studies (Table 1). CMA was used as the 
outcome in three studies, any food allergy in eight studies and egg allergy in two 
studies. Studies on CMA had a cohort design, whereas cross-sectional design was 
the dominant study design in studies on any/other food allergies. Studies were 
conducted mainly in Europe or North America. The size of the study population 
varied from 154 to 102,353 subjects, and all studies included both boys and girls. 
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Two studies were solely register-based, while in other studies the outcome was 
obtained from medical examination or questionnaires and the exposures from 
questionnaires or registers/medical records. 
Since the year 2000, 46 large cohort studies on maternal background and peri-
natal factors and asthma have been published (Table 2). The majority of these 
studies were conducted in Europe or North America. The size of the study popula-
tion varied from 1,033 to 1,576,700 subjects and all studies included both boys 
and girls. Data were obtained solely from registers or medical records in 21 stud-
ies, of which 18 had a sample size of over 10,000 subjects. In other studies, infor-
mation on outcome and exposure was obtained either from questionnaires only or 
from both questionnaires and registers/medical records. Only a minority (ten) of 
the studies reported associations on several (>4) different maternal and perinatal 
factors at the same time. 
 
Maternal age 
Evidence on the association between maternal age and the risk of food allergies is 
limited to one case-control study (Dioun et al. 2003) reporting an increased risk of 
any food allergy by age 11 years in those children whose mothers were older than 
30 years at the delivery compared with children whose mothers were younger 
(Table 1). Maternal age at delivery has been observed to be inversely associated 
with the risk of asthma in two studies (Nafstad et al. 2000, Yuan et al. 2003), di-
rectly associated in one study (Juhn et al. 2005), and not associated in two studies 
(Kiechl-Kohlendorfer et al. 2007, Midodzi et al. 2010) (Table 2). Studies by 
McKeever et al. (2001) and Bråbäck et al. (2003) found age-dependent associa-
tions; the inverse association was stronger or present in children diagnosed with 
asthma at early ages, whereas the association was weaker or not present in chil-
dren diagnosed at older ages. 
 
Maternal socioeconomic status 
In the course of history, asthma and allergic diseases have been considered as 
conditions of relatively affluent populations, although recent evidence on the asso-
ciation between parental socioeconomic status and food allergies and asthma in 
children is controversial (Tables 1 and 2). Two recent studies have reported a de-
creased risk of food allergy in children with low family income (Liem et al. 2007, 
Gupta et al. 2011). Victorino and Gauthier (2009) did not observe an association 
between household income and food allergy, but they observed that children in 
families with a higher education were more likely to have food allergies. Five 
large cohort studies on asthma have reported an inverse association (Nafstad et al. 
2000, Sin et al. 2004, Almqvist et al. 2005, Juhn et al. 2005, Midodzi et al. 2010) 
and three studies a null association (Dik et al. 2004, Hancox et al. 2004, Davidson 
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et al. 2010) between maternal socioeconomic status/income/education and the risk 
of asthma.  
 
Maternal smoking 
Evidence on the role of exposure to smoking on the development of verified food 
allergies is limited (Table 1). A Finnish birth cohort study exploring infant feeding 
patterns and subsequent immunological patterns of CMA reported no association 
between maternal smoking during pregnancy and CMA in the infant (Saarinen and 
Savilahti 2000). On the contrary, maternal smoking during pregnancy is a general-
ly accepted risk factor for respiratory symptoms and reduced lung function, and a 
20%–68% increased risk of asthma in children whose mothers had smoked during 
pregnancy has been reported (Yuan et al. 2003, Jaakkola and Gissler 2004, 
Kiechl-Kohlendorfer et al. 2007, Midodzi et al. 2010) (Table 2). However, also a 
null association (Nafstad et al. 2000) and children's age-dependent associations 
(McKeever et al. 2001, Bråbäck et al. 2003, Davidson et al. 2010) between mater-
nal smoking and the risk of asthma have been reported. In the studies by 
McKeever et al. (2001), Bråbäck et al. (2003) and Davidson et al. (2010), an in-
creased risk of asthma was observed in children diagnosed with asthma at early 
ages, whereas no association was observed in children diagnosed at older ages.  
 
Maternal pregnancy history  
Since Strachan's observation of an inverse association between number of siblings 
and hay fever (Strachan 1989), the association between asthma and thr number of 
siblings, parity, birth order or sibship size has been further explored in several 
studies (Karmaus and Botezan 2002). Saarinen and Savilahti (2000) reported no 
association between presence of siblings and CMA in infancy (Table 1). Similarly, 
Eggesbo and co-workers (2003) reported no association between older siblings 
and egg allergy, although three other studies observed that children with older 
siblings were less likely to develop egg or any food allergy (Dioun et al. 2003, 
Koplin et al. 2012, Kusunoki et al. 2012). Four large cohort studies reported a 
decreased risk of asthma in children having older siblings or high birth order (Ball 
et al. 2000, Nafstad et al. 2000, Dik et al. 2004, Midodzi et al. 2010) (Table 2). 
For example, Ball and co-workers (2000) observed a 20% decrease in the risk of 
asthma at ages 6–13 years per each additional sibling. On the contrary, Yuan and 
co-workers (2003) observed an increased risk of antiasthmatic medication use 
during the first year of life in children having older siblings. In addition, null 
(Kiechl-Kohlendorfer et al. 2007) and diagnosis-age-dependent (McKeever et al. 
2001, Bråbäck et al. 2003, Davidson et al. 2010) associations between older sib-
lings and the risk of asthma have been reported. In the studies observing age-
dependent associations, the association was direct in children diagnosed with 
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asthma at early ages and either inverse or null in children diagnosed at older ages 
(McKeever et al. 2001, Bråbäck et al. 2003, Davidson et al. 2010). 
2.4.2 Perinatal factors 
Mode of delivery  
The majority of the studies assessing mode of delivery and the subsequent devel-
opment of CMA, other food allergies or asthma have focused on a comparison 
between caesarean section and vaginal delivery (Tables 1 and 2). Two Norwegian 
cohort studies assessed the association between delivery by caesarean section and 
the risk of CMA, and both studies reported no association (Eggesbo et. al 2005, 
Kvenshagen et al. 2009). Although Eggesbo and co-workers (2005) did not find 
an association in the total population, they observed an increased risk among chil-
dren whose mothers were allergic. No previous studies related to CMA or any 
food allergy have assessed planned and emergency caesarean sections separately 
or assisted and normal vaginal delivery separately. 
Two meta-analyses have recently summarized the association between delivery 
by caesarean section and the risk of asthma (Bager et al. 2008, Thavagnanam et 
al.2008). Both meta-analyses concluded that delivery by caesarean section was 
associated with a roughly 20% increase in the subsequent development of asthma 
compared with vaginal delivery. These meta-analyses included most studies pre-
sented in Table 2, but also studies with smaller sample sizes and various designs. 
Four more recent cohort studies found a direct association (Tollånes et al. 2008, 
Roduit et al. 2009, Magnus et al. 2011, Almqvist et al. 2012a) and one study a 
null association (Midodzi et al. 2010) between caesarean section and the risk of 
asthma. The largest of these most recent studies, a register-based Norwegian co-
hort study (Tollånes et al. 2008), reported a 52% increased risk of asthma by the 
age of 18 in children delivered by caesarean section. This study assessed also 
emergency and planned caesarean section separately, and both section types were 
associated with an increased risk of asthma, although the strength of the associa-
tion was slightly stronger for emergency caesarean. Studies by Smith et al. (2004) 
and Almqvist et al. (2012a) observed similar associations for both emergency and 
planned caesarean section. In addition, some studies have reported an increased 
risk of asthma in children born by assisted vaginal delivery compared with chil-
dren born by normal spontaneous vaginal delivery (Xu et al. 2000, Tollånes et al. 
2008, Keski-Nisula et al. 2009, Hancox et al. 2013), whereas also null associa-
tions with assisted vaginal delivery have been reported (McKeever et al. 2002a, 
Bernsen et al. 2005). 
 
Twin and other multiple pregnancies 
There is currently no evidence related to multiple pregnancy and the development 
of CMA or other food allergies. Studies on asthma have reported a 15–53% de-
Review of the literature 
 
THL — Research 125 • 2014 29 Perinatal factors, antibiotics and childhood allergies 
 
creased risk among twins compared with singletons (Strachan et al. 2000, 
McKeever et al. 2001, Dik et al. 2004) (Table 2). 
 
Complications during pregnancy 
All five cohort studies exploring the association between the presence of various 
complications and the risk of asthma in the offspring have reported increased risks 
(Nafstad et al. 2000, Annesi-Maesano et al. 2001, McKeever et al. 2002b, Nafstad 
et al. 2003, Dik et al. 2004) (Table 2). There was, however, some variation in the 
strength of the associations between different complications: ORs varied from 
1.43 for hemorrhage to 2.33 for preterm contractions (Nafstad et al. 2003). Fur-
ther, only weak or no association was observed with maternal hypertension or 
preeclampsia (McKeever et al. 2002b, Nafstad et al. 2003). 
 
Gestational age and children's anthropometric measures at birth 
Evidence on fetal growth and the risk of CMA and other food allergies is limited. 
Low birth weight has been associated with a decreased risk of food allergy 
(Hikino et al. 2001, Koplin et al. 2012), but also no association between low birth 
weight and/or gestational age has been reported (Hikino et al. 2001, Liem et al. 
2007) (Table 1). Liem and co-workers (2007) assessed also the role of high birth 
weight on food allergy, but they failed to find an association. On the contrary, 
several studies have explored associations between gestational age and birth 
weight and the risk of asthma, with inconsistent findings (Table 1). Nine cohort 
studies have reported short gestational age or prematurity to be a risk factor for the 
subsequent development of asthma (McKeever et al. 2002a, Yuan et al. 2003, Dik 
et al. 2004, Jaakkola and Gissler 2004, Bernsen et al. 2005, Gessner and Chimo-
nas 2007, Dombkowski et al. 2008, Örtqvist et al. 2009, Vogt et al. 2011), but no 
such association was found in four other studies (Annesi-Maesano et al. 2001, 
Yuan et al. 2002, Taveras et al. 2006, Abe et al. 2010) (Table 2). Further, studies 
by Davidson et al. (2010) and Bråbäck et al. (2003) found children's age-
dependent associations with low gestational age: an increased risk of asthma was 
observed in children diagnosed with asthma at early ages, whereas no association 
was observed in children diagnosed at older ages. Previous studies on birth weight 
and the risk of asthma are even more contradictory than those with gestational age. 
Ten studies have reported low birth weight to be associated with an increased risk 
of asthma (Annesi-Maesano et al. 2001, McKeever et al. 2002a, Dik et al. 2004, 
Jaakkola and Gissler 2004, Juhn et al. 2005, Nepomnyaschy and Reichman 2006, 
Örtqvist et al. 2009, Kindlund et al. 2010, Midodzi et al. 2010, To et al. 2012), but 
five studies failed to find an association (Yuan et al. 2002, Yuan et al. 2003, 
Taveras et al. 2006, Caudri et al. 2007, Kiechl-Kohlendorfer et al. 2007). Similar 
to gestational age, Davidson and co-workers (2010) observed an increased risk 
with low birth weight only in children diagnosed during the first two years of life, 
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but not among those diagnosed later. High birth weight has been associated with 
both an increased risk (Brooks et al. 2001, Sin et al. 2004, Remes et al. 2008) and 
a decreased risk (To et al. 2012) of asthma, but also null associations have been 
reported (Yuan et al. 2002, Yuan et al. 2003, Bernsen et al. 2005, Taveras et al. 
2006). 
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2.4.3 Use of antibiotics 
Antibiotics are natural or synthetic drugs which inhibit microbial growth or kill 
microbes such as bacteria. In Finland, 2.5 million courses of antibiotics are pre-
scribed annually in the primary healthcare system, and the majority (80%) of these 
courses are prescribed for respiratory tract infections (Rautakorpi et al. 2001). 
According to a survey assessing current treatment practices for common infections 
in Finnish primary care, the most common (84%) infections among children less 
than five years of age were respiratory tract infections with otitis media and upper 
respiratory tract infections comprising the majority (70%) of these infections 
(Rautakorpi et al. 2001). The corresponding figure for these two respiratory infec-
tions among children aged 5–14 years was 52%. The most frequently used antibi-
otic for otitis media infections was amoxicillin (53% of antibiotics prescribed for 
otitis media), followed by macrolides (16%) and sulphatrimetoprim (16%). For 
upper respiratory tract infections the most frequently used antibiotics were macro-
lides (28%) and amoxicillin (27%). The most commonly prescribed antibiotics 
were different in adults and in children due to different infection profiles. In chil-
dren, the most common antibiotic agent was amoxicillin (45% of all antibiotic 
prescriptions).  
Increasing bacterial resistance to antibiotics is a major public health threat 
worldwide (Hawkey 2008) and a significant contributing factor to this problem is 
the frequent use of antibiotics. In addition, the adverse effect of antibiotics on 
human microbiota has received increasing attention as an important threat to indi-
vidual's short- and long-term health. The association between children's exposure 
to antibiotics during early childhood and the development of asthma and other 
allergic diseases such as eczema and hay fever has been studied extensively, 
whereas food allergies and prenatal exposure to antibiotics has received less atten-
tion. The results of the studies exploring the association between exposure to anti-
biotics and the risk of asthma or wheeze in childhood or adolescence are summa-
rized in Tables 3 and 4. 
 
Maternal use of antibiotics 
No studies assessing the association between maternal use of specific or any anti-
biotics during pregnancy and the risk of CMA have been published previously. A 
Norwegian cohort study of 2803 children reported no association between the 
maternal use of antibiotics and the risk of egg allergy in the offspring (OR 1.1, 
95% CI 0.3–4.9) (Eggesbo et al. 2003).  
Maternal use of antibiotics during pregnancy and the risk of asthma or wheeze 
in the offspring has been explored in nine studies (Table 3). Six studies had a co-
hort design, one study was a nested case-control study, one a case-control study 
and one a cross-sectional study. The majority of the studies were conducted in 
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Europe, and the size of the study population varied from 102 to 571,277 subjects. 
Information on outcome and exposure was obtained solely from registers or medi-
cal records (four studies), solely from questionnaires (four studies) or from both 
questionnaires and records (one study). The outcome was defined based on diag-
nosed asthma, antiasthmatic drug use or wheezing symptoms. 
An increased risk of asthma or wheeze in the offspring who were exposed to 
antibiotics prenatally was observed in five studies (Benn et al. 2002, McKeever et 
al. 2002b, Jedrychowski et al. 2006, Martel et al. 2009, Källén et al. 2013), but 
three studies found no association (Calvani et al. 2004, Rusconi et al. 2007, Dom 
et al. 2010). The largest cohort study reported a 10% increased risk of asthma in 
children whose mothers were non-asthmatic and had used antibiotics during preg-
nancy (Källén et al. 2013). McKeever and co-workers (2002b) found only minor 
variation between the strength of the associations with different specific antibiot-
ics, while in the study by Stensballe et al. (2013) the strongest association was 
observed for macrolides. In addition, Stensballe and co-workers (2013) observed 
that maternal antibiotics for both non-respiratory infections and other indications 
were associated with an increased risk of asthma. 
 
Children’s use of antibiotics 
Evidence on the role of children’s use of antibiotics in the development of CMA 
or food allergies is limited. Eggesbo and co-workers (2003) assessed in a cohort of 
2803 children whether exposure to antibiotics during the first six months of life 
was associated with subsequent development of egg allergy among children fol-
lowed from birth to three years of age, but they failed to find an association (OR 
1.5, 95% CI 0.6–3.7). However, children's use of antibiotics and the subsequent 
development of asthma or wheeze has been explored more extensively, and 22 
cohort/nested case-control studies have been published thus far. The majority of 
the studies were conducted in Europe and North America. The size of the study 
population varied from 154 to 251,817 subjects and the age from 0 to 10 years. 
Over half of the studies obtained information on outcome and exposure solely 
from questionnaires (13 studies). Six studies were register- or record-based, and 
one study used both questionnaires and records. The outcome was defined based 
on diagnosed asthma, antiasthmatic drug use, asthma hospitalization, asthma or 
wheezing symptoms, or various combinations of these. The most commonly used 
exposure period was the first year of life, but also different periods from the first 
six months to the first three years were used.  
A systematic review and meta-analysis of studies on antibiotics and asthma 
published by September 2004 concluded that exposure to antibiotics during the 
first year of life was associated with an increased risk of asthma in childhood, but 
the association was significantly stronger in retrospective studies than in prospec-
tive studies (Marra et al. 2006). Since this meta-analysis, several cohort studies on 
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asthma or wheeze have been published, but the results have been inconsistent 
(Table 4). Recently, two systematic reviews, including cohort studies published 
before year 2011, concluded that exposure to antibiotics was associated with a 
weak increase in risk of asthma or wheeze (Murk et al. 2011, Penders et al. 2011). 
The largest studies assessing the dose-response effect of antibiotics reported a 
30% to 99% increased risk of asthma in children exposed to antibiotics five, six or 
more times during early childhood (McKeever et al. 2002c, Kozyrskyj et al. 2007, 
Marra et al. 2009, Almqvist et al. 2012b). Age-dependent associations have been 
observed in some studies: the association between exposure to antibiotics and the 
risk of asthma was found to be stronger in children diagnosed at early ages than in 
later childhood (McKeever et al. 2002c, Marra et al. 2009). Further, an increased 
risk of asthma has been observed in children diagnosed at early ages, but not in 
children diagnosed at older ages (Celedon et al. 2004, Mai et al. 2010). The 
child’s use of macrolides, cephalosporins and amoxicillin (McKeever et al. 2002c, 
Marra et al. 2009) as well as penicillins (Marra et al. 2009) and broad-spectrum 
antibiotics (Kozyrskyj et al. 2007, Wickens et al. 2008, Almqvist et al. 2012) has 
been associated with an increased risk of asthma, although one study reported that 
no particular specific antibiotic was associated with the risk of asthma (Celedon et 
al. 2004). 
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3 Aims of the study  
The aim of this study was to assess whether maternal and perinatal factors and the 
use of antibiotics are associated with the development of CMA and asthma in 
childhood. More precisely, the study aimed to answer the following questions: 
 
• Are maternal background factors, including maternal age, socioeconomic sta-
tus, smoking during pregnancy and pregnancy history, associated with the risk 
of CMA or asthma in the offspring? 
 
• Are perinatal factors, including mode of delivery, complications during preg-
nancy and anthropometric measures of the child at birth, associated with the 
risk of CMA or asthma in childhood? 
 
• Is the use of antibiotics by the mother before and during pregnancy associated 
with the risk of CMA or asthma in the offspring? 
 
• Is the use of antibiotics by the child during early childhood associated with the 
risk of CMA or asthma 
 
In addition, this study aimed to examine the determinants of use of antibiotics: i.e. 
are maternal background factors and/or perinatal factors associated with maternal 
and child use of antibiotics? 
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4 Subjects and methods  
4.1 Data sources 
Data for the present study were obtained from four national registers: the Special 
Reimbursement Register, the Population Register and the Drug Prescription Reg-
ister maintained by the Social Insurance Institution and the Medical Birth Register 
maintained by the National Institute for Health and Welfare (Table 5). All the 
registers include the mothers’ and children’s unique personal identity codes, which 
are assigned to all Finnish citizens shortly after birth. Linkages between the regis-
ters were based on these identity codes.  
Table 5. Data sources: name of the register, maintaining institution and 
information obtained from the register  
Register Maintainer Information on 
the Special Reim-
bursement Register 
the Social Insurance 
Institution 
start and end dates of granted special reim-
bursements, disease code (based on diag-
nosed cow’s milk allergy or asthma), personal 
identity code 
the Population 
Register 
the Social Insurance 
Institution 
date of birth, gender, hospital district were the 
child was born and personal identity code 
the Drug Prescripti-
on Register 
the Social Insurance 
Institution 
date of dispense of antiasthmatic drugs, special 
infant formulas and antibiotics, ATC code, 
personal identity code 
the Medical Birth 
Register 
National Institute for 
Health and Welfare 
maternal bakcground and perinatal factors, 
personal identity code 
Abbreviations: ATC= Anatomical Therapeutic Chemical 
 
The Special Reimbursement Register and the Population Register were used to 
respectively select cases and controls. In Finland, patients with a certificate from a 
physician stating that the diagnostic criteria of certain diseases (i.e. asthma) are 
fulfilled are entitled to special reimbursement of the drug costs. In the case of 
CMA, the special reimbursement is for the cost of special infant formulas, and the 
special reimbursement is available for children up to two years of age. In the case 
of asthma, the special reimbursement is available for children of any age. 
The Drug Prescription Register was established in 1993 and was almost com-
plete in 1995. This register includes information on all drugs and special infant 
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formulas prescribed by physicians, reimbursed by the National Sickness Insurance 
Scheme and dispensed from the pharmacists. The Drug Prescription Register in-
cludes information on drug class (Anatomical Therapeutic Chemical [ATC] Clas-
sification System) and dispensing date of the prescription. Information on pur-
chased antibiotics, antiasthmatic drugs and special infant formulas was obtained 
from the Drug Prescription Register. In Finland, outpatient antibiotics are availa-
ble by prescription only. The Finnish Medical Birth Register includes information 
on mother's sociodemographic background, maternal health care and interventions 
during pregnancy and delivery, and the newborn's medical interventions and out-
come up to the age of seven days.  
The study was approved by the national data protection authority, the institu-
tions keeping the registers and the Institutional Review Board of the National 
Public Health Institute (National Institute for Health and Welfare since 2009). 
4.2 Study design and population 
This study was a nested case-control study. The study population was selected 
from a birth cohort consisting of all children born in Finland between 1 January 
1996 and 30 April 2004. From this initial birth cohort, all children with a diag-
nosed CMA or asthma were identified. For each case, one control child without a 
diagnosed index disease and matched to the case by age (±28 days), gender and 
hospital district in which the child was born was randomly selected at each time 
when the case occurred. Controls were allowed to be selected only once and twins 
from the same family as case-control pairs were not allowed. The Medical Birth 
Register data were not available for the children who were not born in Finland, 
and these children were excluded from the study population. 
4.2.1 Cow's milk allergy population 
All children who belonged to the initial birth cohort and had received a special 
reimbursement for the costs of special infant formulas (soy-based, extensively 
hydrolysed or elemental infant formulas) prescribed for the management of their 
diagnosed CMA by the end of November 2005 were identified (n=19,111) (Figure 
1). The Social Insurance Institution's criteria for the special reimbursement for 
CMA included a clinical examination with a careful history, symptoms suggestive 
of CMA and disappearance of the symptoms when cow’s milk was eliminated 
from the diet. Further, either a positive skin-prick test, an elevated serum specific 
IgE or an open challenge test performed in the hospital’s in- or out-patient unit 
were required. In Finland, most cases had a final confirmation of the diagnosis 
based on an open challenge test (Kaila et al. 2000). For a strict definition of CMA 
case for the present study, infants with a special reimbursement of short duration 
(< 6 months) or none or only occasional purchases (maximum two purchases) of 
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special infant formulas or both were excluded. Finally, 16,237 case-control pairs 
were included in the CMA population. 
4.2.2 Asthma population 
All children who belonged to the initial birth cohort and had received a special 
reimbursement for the cost of antiasthmatic drugs by the end of 2005 were identi-
fied (n=22,548) (Figure 1). The Social Insurance Institution's criteria for the spe-
cial reimbursement for asthma included a diagnosis made according to explicit 
predefined diagnostic criteria and a plan of a long-lasting (at least six months) 
drug therapy. For a strict definition of an asthma case for the present study, chil-
dren with no antiasthmatic drug purchases after the diagnosis were excluded. Se-
lection of the antiasthmatic drugs was based on the Finnish Current Care guide-
lines of asthma and the recommendations by the Social Insurance Institution. In 
addition, those control children who had purchased antiasthmatic drugs from birth 
until the date of asthma diagnosis of the case without special reimbursement were 
excluded. Finally, 20,272 case-control pairs were included in the asthma popula-
tion. As asthma is challenging to diagnose in young children, the asthma popula-
tion was further divided into children diagnosed before the age of three years (n= 
13,582 case-control pairs, the younger age group) and children diagnosed between 
the age of three and nine years (n= 6,690 case-control pairs, the older age group). 
The age division was based on national diagnostic criteria (Asthma: Current Care 
Summary. 2012) and international observations of different wheezing phenotypes 
(Martinez et al. 1995).  
4.3 Data collection 
4.3.1 Maternal background and perinatal factors 
The maternal sociodemographic background variables extracted from the Medical 
Birth Register were age at delivery, smoking during pregnancy and socioeconomic 
status. The variables related to maternal pregnancy history and index pregnancy 
were previous miscarriages, previous deliveries and complications during preg-
nancy as well as mode of delivery and gestational age. Child-related variables 
were birth weight, birth length, ponderal index (birth weight/birth length3) and 
Apgar score at one minute after birth. In addition, the variables gestational age 
adjusted birth weight, prematurity and low birth weight were calculated. Infor-
mation on maternal asthma – based on granted special reimbursement for the costs 
of antiasthmatic drugs – was obtained from the Special Reimbursement Register 
of the Social Insurance Institution. Detailed information on maternal background 
and the perinatal factors used in the present study is presented in the Appendix 1. 
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4.3.2 Antibiotics 
To evaluate the maternal use of antibiotics, information on all antibiotics (ATC 
code J01, antibacterials for systemic use) purchased during pregnancy and one 
year preceding pregnancy was extracted. The term of pregnancy was calculated 
from the date of birth of the child and gestational age obtained from the Medical 
Birth Register. In the absence of information on gestational age (n= 224, 0.6% in 
the asthma population and n=121, 0.7% in the CMA population) an assumption of 
280 days was made. To evaluate the children’s use of antibiotics, information on 
all antibiotics purchased from birth until the date of CMA or asthma diagnosis of 
the case was extracted. In the CMA population, antibiotics purchased in the month 
before diagnosis were excluded in order to diminish reverse causation due to anti-
biotics prescribed during the diagnosis process. In the asthma population, antibiot-
ics purchased in the six months before diagnosis were excluded in order to dimin-
ish protopathic bias (i.e. the early symptoms of an undiagnosed asthma could have 
been the reason for the use of antibiotics). To evaluate the determinants of antibi-
otic use, only antibiotics used among control mothers and control children were 
taken into account. Variables used to assess the use of antibiotics were defined and 
categorized based on exposure period, number of purchases, type of antibiotic and 
indication (Appendix 2). 
4.4 Statistical analysis 
To examine the associations between maternal background factors and perinatal 
factors among control mothers and children, the Pearson chi-squared test for two 
categorical variables, the Mann-Whitney U test for the combination of a continu-
ous and a dichotomous variable, and the Spearman rank correlation for two con-
tinuous variables were used. Logistic regression was used to examine the determi-
nants of the use of antibiotics among control mothers and control children.  
The associations between maternal background factors, perinatal factors and 
the use of antibiotics and the risk of CMA or asthma were analysed by conditional 
logistic regression. A test for trend was performed by fitting a conditional logistic 
regression model for the linear effect of maternal age, gestational age, ponderal 
index, birth weight, birth length and the number of antibiotic purchases using a 
likelihood ratio test. To examine interactions between selected variables, an inter-
action term was included in the crude and adjusted models (see below) and a like-
lihood ratio test was used to compare the models with and without the interaction 
term. In the asthma population, all analysis was conducted separately for children 
diagnosed before the age of three years and at the age of three years or later. Sta-
tistical significance was set at the five percent level and two-sided P values were 
used. All analyses were performed using Version 9.1 of STATA software.  
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Models for maternal background and perinatal factors and the risk of cow’s 
milk allergy and asthma  
Firstly, a model with only one explanatory variable at a time was fitted. The pon-
deral index, the Apgar score at one minute, the mode of delivery, the multiple 
pregnancy and complications were, however, adjusted for gestational age in the 
univariate analysis. Secondly, a multivariate model was fitted. The variables in-
cluded in the multivariate models in the CMA and asthma populations are present-
ed in Table 6. 
Table 6. Variables included in the multivariate models estimating the 
associations between maternal background factors, perinatal factors 
and the risk of cow’s milk allergy and asthma  
Variable Outcome 
 Cow's milk 
allergy 
Asthma 
(diagnosis <3 yr) 
Asthma 
(diagnosis ≥3yr) 
Maternal age x x x 
Maternal asthma  x x 
Maternal smoking during pregnancy x x x 
Maternal socioeconomic status x   
Maternal previous deliveries  x x x 
Maternal previous miscarriages  x x 
Multiple pregnancy x   
Mode of delivery x x x 
Gestational age x x x 
Ponderal index x x x 
x = included in the model  
 
Models for use of antibiotics and the risk of cow’s milk allergy and asthma  
Both unadjusted and adjusted models were fitted, and the maternal background 
and perinatal factors associated with both CMA or asthma and the use of antibiot-
ics were included as confounders in the adjusted models. The variables included in 
the main adjusted models for maternal and child use of antibiotics in the CMA and 
asthma populations are presented in Table 7. 
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Table 7. Variables included as confounders in the main adjusted models 
estimating the associations between maternal and child use of 
antibiotics and the risk of cow’s milk allergy and asthma  
Variable Outcome 
 Cow's milk 
allergy 
Asthma 
(diagnosis <3 yr) 
Asthma 
(diagnosis ≥3yr) 
 Mother Child Mother Child Mother Child 
Maternal age x x x x   
Maternal asthma   x x x x 
Maternal smoking during pregnancy x x x x   
Maternal socioeconomic status x      
Maternal previous deliveries  x x x x x x 
Maternal previous miscarriages   x x   
Multiple pregnancy x      
Mode of delivery  x  x   
Gestational age    x  x 
Birth weight  x     
Child use of antibiotics x  x  x  
x = included in the model 
 
The models for child’s use of antibiotics were adjusted further with the maternal 
use of antibiotics preceding and during pregnancy. In addition, the models for the 
use of specific antibiotics were adjusted further for the total number of antibiotic 
purchases from which the number of corresponding specific antibiotic purchases 
was excluded. 
As a result of excluding antibiotics purchased one month and six months be-
fore diagnosis in the CMA and asthma populations, analysis was restricted to chil-
dren diagnosed after the age of one month in the CMA population (n=15,672 case-
control pairs) and to children diagnosed after the age of six months but before the 
age of three years (n=12,427 case-control pairs) in the younger asthma age group.  
The results of this study are presented as adjusted odds ratios (ORs) and 95 
percent confidence intervals (CIs) obtained from the multivariate models (mater-
nal background and perinatal factors) and the main adjusted models (antibiotics). 
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4.5 Ethical issues 
This study was based on information originally collected for administrative pur-
poses. The present study did not require any contact with the participants. Under 
Finnish law no written consent is needed from the participant or their caretakers in 
register-based studies. To use administratively collected information for scientific 
study purposes from those registers that allow it, permission from the institutions 
keeping the registers and an ethics approval is required. The study protocol of the 
present study was approved by the institutions keeping the registers used in this 
study and the Institutional Review Board of the former National Health Institute 
(now the National Institute for Health and Welfare). 
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5 Results  
5.1 Characteristics of the study population 
The mean age at receiving a special reimbursement for CMA was 6.0 months (SD 
3.7 months, range 0.0 to 22.9 months) and 1.6 years (SD 0.7 years, range 0.0 to 
2.9 years) for asthma in the younger age group and 4.8 years (SD 1.4 years, range 
3.0 to 9.7 years) for asthma in the older age group. The majority (91%) of the 
CMA cases were diagnosed before the age of 12 months and two-thirds (67%) of 
all asthma cases before the age of three years. Both CMA and asthma diagnosed at 
any age were more common in boys than in girls (59% vs. 41% and 64% vs. 36%, 
respectively) (Table 8).  
One-third of the mothers in the CMA and asthma populations belonged to the 
age groups 25–29 years or 30–34 years and less than 20 percent to the youngest 
age group (<25 years at the time of delivery)(Table 8). A large proportion of the 
mothers were lower white-collar workers and had previously delivered one or two 
children (Table 8). 
5.2 Association between maternal background factors and 
the risk of cow's milk allergy and asthma 
Several maternal background factors were associated with the risk of CMA and 
asthma (Table 9). While maternal age was directly associated with CMA, it was 
inversely associated with asthma diagnosed before the age of three years and not 
associated with asthma diagnosed at the age of three years or later. Maternal high 
socioeconomic status was associated with an increased risk of CMA, while the 
socioeconomic status was not associated with asthma. Maternal smoking during 
pregnancy was associated with a decreased risk of CMA and an increased risk of 
asthma diagnosed in early childhood, but not associated with asthma diagnosed at 
the age of three years or later. Maternal asthma was associated with an increased 
risk of asthma in both age groups. No information on maternal allergic back-
ground was available in the CMA population. 
The number of maternal previous deliveries was inversely associated with 
CMA and asthma diagnosed at the age of three years or later, but directly with 
asthma diagnosed before the age of three years. Maternal previous miscarriages 
were associated only with asthma in the younger age group. 
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Table 8. Characteristics of the cow’s milk allergy and asthma study populations  
Factors Cow's milk  
allergy 
Asthma 
(diagnosis <3 yr) 
Asthma 
(diagnosis ≥3yr) 
 Cases1 Controls Cases1 Controls Cases1 Controls 
 % % % % % % 
Maternal age (years)       
   <25 15 19 20 9 21 19 
   25–29 33 33 34 31 35 33 
   30–34 34 30 31 31 29 31 
   ≥35 18 18 16 19 15 18 
Maternal socioeconomic status       
   Upper white-collar workers 23 18 16 19 16 17 
   Lower white-collar workers 47 44 47 45 49 45 
   Blue-collar worker 13 18 16 17 17 18 
   Others 17 20 21 20 18 20 
Maternal smoking during  
pregnancy  
      
   No 90 85 81 86 85 86 
   Yes 10 15 19 15 15 15 
Number of maternal previous 
deliveries 
      
   0 41 42 33 42 47 40 
   1–2 51 48 54 49 46 50 
   ≥3 8 10 13 10 7 10 
Child's sex       
   Male  59 59 66 66 60 60 
   Female 41 41 34 34 40 40 
1 Cases and controls were matched on sex, date of birth (±28 days) and the hospital district in 
which the child was born 
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Table 9. Summary of the associations between maternal background and 
perinatal factors and the risk of cow’s milk allergy and asthma  
Factor Outcome 
 Cow's milk 
allergy 
Asthma 
(diagnosis <3 yr) 
Asthma 
(diagnosis ≥3yr) 
Maternal background factors    
Age  ↑ ↓ ns 
Socioeconomic status  ↑ ns ns 
Smoking during pregnancy ↓ ↑ ns 
Previous deliveries  ↓ ↑ ↓ 
Previous miscarriages ns ↑ ns 
Perinatal factors    
Caesarean section  ↑ ↑ ns 
Multiple pregnancy ↓ ns ns 
High blood pressure ns ns ns 
Placental complications ns ↑ ns 
Fetal abnormal presentation ns ns ns 
Gestational age  ns ↓ ↓ 
Prematurity (<37 gestational weeks) ns ↑ ↑ 
Low Apgar score  ns ↑ ↑ 
Ponderal index  ns ↓1 ↓1 
Birth weight  ↑ ns ns 
Birth length  ns ns ns 
Low birth weight (birth weight <2500g) ns ↑ ns 
Small-for-gestational-age ns ↑ ns 
Large-for-gestational-age ns ns ns 
Abbreviations: ↑ direct association with the outcome, ↓ inverse association with the outcome, ns 
not associated with the outcome  
1 not associated with asthma when prematurely born children were excluded 
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5.3 Association between perinatal factors and the risk of 
cow's milk allergy and asthma 
Delivery by both planned and unplanned caesarean section was associated with an 
increased risk of CMA and asthma diagnosed in early childhood (both section 
types combined, OR 1.18, 95% CI 1.10–1.27 for CMA and OR 1.27, 95% CI 
1.19–1.37 for asthma diagnosed before the age of three years)(Table 9). Multiple 
pregnancy was associated with a decreased risk of CMA. Most maternal complica-
tions during index pregnancy were not associated with CMA or asthma except 
placental complications, which were associated with an increased risk of asthma 
diagnosed before three years of age.  
None of the variables indicating restricted fetal growth (short gestational age, 
low birth weight, small-for-gestational age or low ponderal index) were associated 
with CMA. Short gestational age was associated with asthma diagnosed at any 
age, but low birth weight, small-for-gestational age and low Apgar score were 
only associated with asthma diagnosed in early childhood. High birth weight was 
associated with an increased risk of CMA, but none of the other factors indicating 
enhanced fetal growth (large-for-gestational age or high ponderal index) were 
associated with either CMA or asthma. 
5.4 Use of antibiotics 
In the year preceding pregnancy, 44% of the case mothers in the asthma popula-
tion, 41% of the case mothers in the CMA population and 35% of all control 
mothers had used antibiotics. During pregnancy, 32% of case mothers in the asth-
ma population, 28% of case mothers in the CMA population and 24% of all con-
trol mothers had used antibiotics. In addition, 19% of case mothers in the asthma 
population, 16% of case mothers in the CMA population and 12% of all control 
mothers and had used antibiotics both before and during pregnancy.  
Among the children, 21% of the CMA cases and 15% of the CMA controls had 
used antibiotics at least once during the follow-up period from birth to the diagno-
sis date of the case (Table 10). In the asthma population, 56% of asthma cases 
diagnosed before the age of three years and 35% of control children had used anti-
biotics at least once during the first year of life. The corresponding figures for 
asthma cases diagnosed at the age of 3 years or later and their controls were 58% 
and 49% respectively. Further, the prevalence of frequent use (six or more pur-
chases) of antibiotics during the first three years of life was 45% in cases and 26% 
in controls followed for at least three years. The most commonly used specific 
antibiotic among all children during the first year of life was amoxicillin, followed 
by macrolides and cephalosporins (Table 10). 
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5.4.1 Determinants of antibiotic use 
Maternal asthma, smoking during pregnancy and previous deliveries were directly 
associated with the use of antibiotics during pregnancy by the control mothers in 
both the CMA and asthma populations. Similar associations were observed be-
tween maternal background factors and the use of antibiotics before pregnancy.  
Maternal age, previous deliveries, previous miscarriages, child ponderal index 
or birth weight, male sex and maternal use of antibiotics were directly associated 
with the use of antibiotics by the control children in both the CMA and asthma 
populations (Table 11). 
Table 11. Summary of the determinants of antibiotic use among control children 
in the cow’s milk allergy and asthma populations  
Factor Population 
 Cow's milk allergy1 Asthma2 
Maternal age ↑ ↑ 
Maternal socioeconomic status ns ns 
Maternal smoking during pregnancy ns ns 
Maternal previous deliveries  ↑ ↑ 
Maternal previous miscarriages ↑ ↑ 
Caesarean section ns ↑ 
Gestational age ns ns 
Ponderal index/birth weight ↑ ↑ 
Male sex ↑ ↑ 
Maternal use of antibiotics ↑ ↑ 
Abbreviations: ↑ direct association with the use of antibiotics, ↓ inverse association with the use of 
antibiotics, ns not associated with the use of antibiotics 
1 use of antibiotics defined as overall use from birth to diagnosis date of the case 
2 use of antibiotics defined as frequent use from birth to three years of age 
 
5.4.2 Association between maternal use of antibiotics and the risk of 
cow´s milk allergy and asthma in offspring 
Before pregnancy, maternal overall use of antibiotics was associated with an in-
creased risk of CMA (OR 1.26, 95% CI 1.20–1.33) and asthma in the offspring 
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(OR 1.28, 95% CI 1.21–1.37 for asthma diagnosed before the age of three years 
and OR 1.20, 95% CI 1.10–1.30 for asthma diagnosed at the age of three years or 
later) when adjusting for several maternal background factors, perinatal factors 
and the children’s use of antibiotics. In addition, the risk of CMA and asthma 
increased with an increasing number of antibiotic purchases (P for trend <0.001) 
(Figure 2). 
 
 
Figure 2. Associations between number of maternal antibiotic purchases before 
pregnancy and the risk of cow s milk allergy and asthma in the off-
spring. Data points are adjusted odds ratios (light gray circle, cow's milk 
allergy; grey triangle, asthma diagnosed before the age of 3 years; 
black square, asthma diagnosed at the age of 3 years or later) with 
95% confidence intervals (bars), 0 purchases as reference.  
 
During pregnancy, maternal overall use of antibiotics was associated with an 
increased risk of CMA (OR 1.21, 95% CI  1.14–1.28) and asthma (OR 1.28, 95% 
CI 1.20–1.37 for asthma diagnosed before the age of three years and OR 1.14, 
95% CI 1.04–1.24 for asthma diagnosed at the age of three years or later) in the 
offspring. In addition, the risk of CMA and asthma increased with an increasing 
number of antibiotic purchases (P for trend <0.001) (Figure 3).  
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Figure 3. Associations between number of maternal antibiotic purchases during 
pregnancy and the risk of cow s milk allergy and asthma in the off-
spring. Data points are adjusted odds ratios (light gray circle, cow's milk 
allergy; grey triangle, asthma diagnosed before the age of 3 years; 
black square, asthma diagnosed at the age of 3 years or later) with 
95% confidence intervals (bars), 0 purchases as reference. 
 
When taking potential confounders and the total number of antibiotic purchas-
es into account, maternal use of cephalosporins, macrolides and penicillins with 
extended spectrum both before and during pregnancy was associated with an in-
creased risk of CMA and asthma in the younger age group, while only cephalo-
sporins used both before and during pregnancy were associated with an increased 
risk of asthma in children diagnosed at the age of three years or later (Table 12). In 
addition, use of tetracyclines before pregnancy, but not during pregnancy was 
associated with an increased risk of CMA and asthma diagnosed before the age of 
three years. When grouping antibiotics used during pregnancy by indication, anti-
biotics for respiratory tract infections were associated with an increased risk of 
asthma diagnosed at the age of three years or later in the offspring. 
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Table 12. Summary of the associations between maternal specific antibiotics 
used before and during pregnancy and the risk of cow’s milk allergy 
and asthma in the offspring  
Type of antibiotic Outcome 
 Cow's milk  
allergy 
Asthma 
(diagnosis <3 yr) 
Asthma 
(diagnosis ≥3yr) 
Cephalosporins ↑ ↑ ↑ 
Penicillins with extended 
spectrum 
↑ ↑ ns 
Macrolides ↑ ↑ ns 
Tetracyclines ↑  
(before pregnancy) 
ns  
(during pregnancy) 
↑ 
 (before pregnancy) 
ns  
(during pregnancy) 
ns 
Phenoxymethylpenicillin ns ns ns 
Sulfonamides and trimetho-
prim 
ns ns ns 
Fluoroquinolones ns ns ns 
Abbreviations: ↑ direct association with the outcome, ns not associated with the outcome 
5.4.3 Association between child use of antibiotics and the risk of 
cow´s milk allergy and asthma  
Both overall use and an increasing number of antibiotics purchased during the first 
year of life were associated with an increased risk of CMA and asthma (Figure 4). 
When extending the exposure period from birth to diagnosis in the asthma popula-
tion, the associations were even stronger (adjusted OR for ≥10 purchases 19.73, 
95% CI 15.30–25.43 in the younger age group and adjusted OR 8.92, 95% CI 
7.41–10.73 in the older age group).  
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Figure 4. Association between number of children's antibiotic purchases and the 
risk of cow s milk allergy and asthma. Data points are adjusted odds ra-
tios (light gray circle, cow's milk allergy; grey triangle, asthma diag-
nosed before the age of 3 years; black square, asthma diagnosed at 
the age of 3 years or later) with 95% confidence intervals (bars), 0 pur-
chases as reference. 
All commonly used specific antibiotics used by the child from birth to diagnosis 
were associated with CMA and asthma, although the use of phenoxymethylpeni-
cillin during the first year of life was not associated with asthma in the older group 
(Table 13). Further grouping of specific antibiotics used during the first year of 
life according to indication did not show clear differences between the effect esti-
mates in children with asthma diagnosed at the age of three years or later (OR 
1.51, 95% CI 1.41–1.63 for antibiotics against respiratory tract infections and OR 
1.54, 95% CI 0.92–2.59 for antibiotics against urinary tract infections). In fact, the 
strongest association was observed when antibiotics belonging to both indication 
groups were used (OR 2.16, 95% CI 1.76–2.66). 
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Table 13. Summary of the associations1 between child's use of specific antibiotics 
and the risk of cow’s milk allergy and asthma  
 Outcome 
 Cow's milk 
allergy 
Asthma 
(diagnosis <3 yr) 
Asthma 
(diagnosis ≥3yr) 
Type of antibiotic Exposure period 
 birth to 
diagnosis2 
first 
year 
birth to 
diagnosis3 
first 
year 
birth to 
diagnosis3 
Amoxicillin ↑ ↑ ↑ ↑ ↑ 
Macrolides ↑ ↑ ↑ ↑ ↑ 
Cephalosporins ↑ ↑ ↑ ↑ ↑ 
Sulfonamides and trimethoprim ↑ ↑ ↑ ↑ ↑ 
Phenoxymethylpenicillin ↑ ↑ ↑ ns ↑ 
Abbreviations: ↑ direct association with the outcome, ns not associated with the outcome 
1 adjusted for potential confounders and the total number of antibiotic purchases 
2 those antibiotics purchased one month preceding the diagnosis date of the case were excluded 
3 those antibiotics purchased six months preceding the diagnosis date of the case were excluded 
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6 Discussion  
6.1 Methodological considerations 
Data sources 
By using the Finnish unique personal identity codes, we were able to establish a 
large, population-based database and link comprehensive information from several 
nationwide registers. Use of personal identity codes as a key in register linkage 
improves the completeness of information in the study (Gissler and Haukka 2004).  
The coverage of Finnish health registers is generally high (Gissler and Haukka 
2004). The Medical Birth Register covers all births in Finland and several varia-
bles included in the register have shown high validity and accuracy (Gissler et al. 
1995). Completeness and accuracy of the Drug Prescription Register is also con-
sidered high (Furu et al. 2010), although not optimal. In 1997–1999 and 2000–
2005 the register respectively covered 70% and 75% of total antibiotic consump-
tion in Finnish outpatients. The most frequent reason for not being covered by the 
database was the low price of medication (a threshold of 10 euros).  
A major strength in using registers is the avoidance of participation, reporting 
and recall bias, which are more an issue in studies based on information obtained 
from questionnaires. Thus, detailed information on both the mother's and the 
child's lifetime antibiotic exposure and several maternal background and perinatal 
factors is one of the unique features of the present study.  
One of the limitations of using register-based data is that information is usually 
collected for administrative purposes and not all information needed for research 
purposes is available. Hence, despite being able to include several putative con-
founders in the present study, information on certain important confounders – such 
as indication of antibiotic prescription, antibiotic exposure at hospitals and certain 
factors presumably affecting the development of diseases like infant feeding and 
parental allergy status – were missed. Thus, residual confounding, referring to the 
situation where an observed association between exposure and outcome is pro-
duced by an unmeasured third factor, can not be ruled out as an explanation for the 
results of the present study. 
 
Study design and population 
This study was a historical cohort study utilizing a nested case-control approach in 
the selection of controls for the cases (incidence density sampling). All original 
information in the registers was collected prospectively and independently of the 
disease status of the child. The prospective nature of the present study diminishes 
bias caused by reverse causation, which could occur when the presumed outcome 
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is responsible for the occurrence of the exposure of interest. Case-control and 
cross-sectional studies are more amenable to this bias, although it may occur in 
cohort studies as well.  
The study population of the present study was large enough to evaluate the as-
sociations between various maternal background factors, perinatal factors and 
antibiotic exposure in detail and the risk of CMA and asthma. However, due to the 
large sample size, the possibility of obtaining statistically significant associations 
even when the differences between the cases and controls were small must be 
taken into account when interpreting the results. On the other hand, some of the 
confidence intervals were rather wide due to the use of wide categories with some 
exposures and the use of several potential confounding factors. Further, the statis-
tical approach needed with match data decreased the number of case-control pairs 
in each category of the exposure.  
Our results on the associations between the use of antibiotics and the risk of 
CMA and asthma may be generalized to other pediatric populations, providing 
that potential differences related to, for example, antibiotic prescription practices 
among other pediatric population are considered. 
 
Outcome and exposure assessment 
The identification of CMA and asthma cases through the Special Reimbursement 
Register can be considered reliable, as the requirement for each special reim-
bursement is based on a clinical diagnosis made by a paediatrician or physician 
and, furthermore, the application is further reviewed against criteria by another 
clinician. In addition, it is worth noting that eligibility for the special reimburse-
ment does not depend on a family’s socioeconomic situation or area of residence. 
However, due to the size of the study population, we were unable to verify indi-
vidually all the diagnoses and thus can not exclude the possibility that some heter-
ogeneity in the diagnostic procedures among our cohort children exists. For exam-
ple, some of the CMA cases with severe reactions to cow’s milk or a very young 
age could have received the special reimbursement without undergoing a chal-
lenge procedure. The number of these CMA cases is, however, likely to be small. 
Further, as wheezing is common in early childhood and objective diagnostic 
measurements for asthma diagnosis are difficult to apply for young children, early 
transient wheezing may be what some of the youngest children in our asthma co-
hort have. However, to at least partly disentangle the fact that we were not able to 
distinguish between different wheezing or asthma phenotypes, all analysis in the 
asthma population was conducted separately for children diagnosed before the age 
of three years and at the age of three years or later. Furthermore, in both popula-
tions we applied a strict case definition which included specific criteria for the 
number of purchased antiasthmatic drugs in asthma cases and the duration of the 
special reimbursement and the number of special infant formula purchases in 
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CMA cases. This further strengthens the reliability of the case definition used in 
the present study. However, despite the strict criteria of asthma cases, some uncer-
tainty regarding the diagnosis in the younger age group is likely, and the results of 
the older age group are considered to be the main findings in the asthma popula-
tion. 
Exposures of the present study – maternal background factors, perinatal factors 
and the use of antibiotics – were obtained from nationwide registers with high 
population coverage and accuracy. However, relying on pharmacy records to as-
sess drug use, the information on drug purchases includes only a rough estimation 
of the actual use. However, data on dispensed drugs suggest a better correspond-
ence with actual drug use than data retrieved from registries based solely on pre-
scriptions would. Further, a misclassification of subjects who failed to take their 
antibiotics as users only dilutes the associations and biases the relative risks to-
ward unity. 
6.2 Maternal background factors as risk factors for cow's 
milk allergy and asthma 
Maternal age, socioeconomic status and smoking 
Limited information on the role of maternal background factors – other than ma-
ternal allergies – in the development of CMA exists. We observed a direct associa-
tion between maternal age and socioeconomic status and CMA. Similarly, a higher 
maternal age and a high socioeconomic status/income have been associated with 
any food allergy in two previous studies (Dioun et al. 2003, Liem et al. 2007). We 
also observed an inverse association between maternal smoking during pregnancy 
and CMA, but another Finnish cohort study failed to find an association between 
maternal smoking and CMA (Saarinen et al. 1999).  
The finding of an increased risk of asthma with low maternal age and smoking 
during pregnancy in the present study is in line with some previous cohort studies 
(Nafstad et al. 2000, McKeever et al. 2001, Yuan et al. 2003), although not all 
(Juhn et al. 2005, Kiechl-Kohlendorfer et al. 2007, Midodzi et al. 2010). Age-
dependent associations similar to those in the present study were found in two 
other studies; low maternal age (Bråbäck et al. 2003) and smoking (Bråbäck et al. 
2003, Davidson et al. 2010) were associated with asthma diagnosed at early ages, 
but not with asthma diagnosed at older ages.  
The associations with maternal age, socioeconomic status and smoking and 
CMA could at least partly support the notion that mothers with a higher socioeco-
nomic status tend to seek consultation for their child's symptoms more often than 
mothers with a lower socioeconomic status. Smoking during pregnancy has been 
related to a younger age and lower socioeconomic status of the mother (Jaakkola 
et al. 2001), and thus the association between maternal age and asthma could re-
flect the social environment and maternal health behaviour. On the other hand, 
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maternal age could be related to the biology of fetal development as well. The 
observation of no association between socioeconomic status and asthma in this 
study may reflect the heterogenic nature of asthma and, on the other hand, the fact 
that socioeconomic status was based on occupation at the time of delivery. This 
may have misclassified some women, as some of the women with an occupation 
that belongs to the highest socioeconomic status group may have reported being 
housewives at the time of delivery. This may explain the proportion of women 
with an unidentified socioeconomic position. Thus, even though the occupational 
information in the Medical Birth Register has been shown to be of high quality 
(Gissler et al. 1995), some uncertainty attributed to the large proportion of women 
with unidentified socioeconomic status remains.  
 
Previous deliveries  
In the present study, the number of maternal previous deliveries was inversely 
associated with the risk of CMA and asthma in the older age group and directly 
with asthma in the younger age group. Evidence related to older siblings or birth 
order and food allergies is limited: three studies have reported an inverse associa-
tion with egg allergy (Koplin et al. 2012) and any food allergy (Dioun et al. 2003, 
Kusunoki et al. 2012) whereas two studies have reported a null association with 
CMA (Saarinen and Savilahti 2000) or egg allergy (Eggesbo et al. 2003). Three 
very large, register-based cohort studies have reported almost similar age-
dependent findings with asthma as in the present study: the risk of asthma was 
increased among the youngest children and decreased or not associated with the 
older children (McKeever et al. 2001, Bråbäck et al. 2003, Davidson et al. 2010). 
The differences in these age-dependent associations are likely due to differences in 
the cut-off points of the diagnosis age or in the outcome definition. Studies by 
Bråbäck et al. (2003) and Davidson et al. (2010) used hospitalization due to asth-
ma as the outcome, whereas McKeever and co-workers (2001) relied on infor-
mation on recoded asthma diagnosis.  
The associations between older siblings or birth order and CMA and asthma 
may have their origin in both the prenatal and postnatal periods. Firstly, it has 
been suggested that the protective association is due to an increased exposure to 
infections in early childhood from close contact with siblings. Furthermore, it has 
been suggested that the more diverse gut microbiota observed in children living in 
large families (Sjögren et al. 2009) could be related to the inverse association 
between number of siblings and development of asthma and allergic diseases. 
Secondly, there is growing evidence to support the prenatal origin of "the birth 
order or sibling effect". As hormonal and immunologic conditions in the uterus in 
subsequent pregnancies are different from those in first pregnancies, this may 
affect the health outcomes of the children later in life. 
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The somewhat divergent associations between maternal sociodemographic 
background factors, pregnancy history and the outcomes, CMA and asthma, ob-
served in the present study may be due to etiological differences between these 
diseases. In addition, the age-dependent findings among the asthma population 
may also be due to etiological differences between asthma starting in earlier rather 
than later childhood, but also due to the fact that some of the children in our 
younger asthma cohort may have had only transient early wheezing rather than 
true asthma. Further, inconsistencies between previous studies exploring the asso-
ciations between maternal factors and the development of CMA, other food aller-
gies and asthma may be due to etiological differences between the diseases or 
methodological differences between the studies, or the inconsistencies may indi-
cate that the associations are only weak, due to change or confounding. 
6.3 Perinatal factors as risk factors for cow's milk allergy 
and asthma 
Mode of delivery 
The finding from the present study that delivery by caesarean section was associ-
ated with and increased risk of CMA has some support from one previously pub-
lished study (Eggesbo et al. 2005). Although this cohort study did not find a statis-
tically significant association, a tendency towards an increased risk of CMA was 
observed (OR 2.5, 95% CI 0.8–7.5) (Eggesbo et al. 2005). Another cohort study 
also failed to find an association between delivery by caesarean section and the 
development of CMA (Kvenshagen et al. 2009), which, however, may have due to 
small sample size and thus lack of power.  
Caesarean section was associated with an increased risk of asthma in the pre-
sent study, which is in line with several register-based asthma studies (Kero et al. 
2002, Smith et al. 2004, Renz-Polster et al. 2005, Tollånes et al. 2008, Almqvist et 
al. 2012a), but not them all (Benn et al. 2002, McKeever et al. 2002a Bernsen et 
al. 2005, Juhn et al. 2005). However, the increased risk in the present study was 
observed only among children diagnosed before the age of three years, but not at 
later age, which is in contrast with findings from the study by Salam et al. (2006). 
This study reported an increased risk of asthma among those children diagnosed 
after the age of 3 years but not earlier. Age-dependent associations have not been 
reported in other studies. The finding that both planned and other caesarean sec-
tions were associated with the risk of asthma in the present study is in line with 
those studies that assessed different caesarean section types (Smith et al. 2004, 
Tollånes et al. 2008, Almqvist et al. 2012a). Further, there is some evidence – 
although it is not consistent – supporting the observation of an increased risk of 
asthma diagnosed in early childhood in children born by assisted delivery (Xu et 
al. 2000, McKeever et al. 2002a, Bernsen et al. 2005, Tollånes et al. 2008, Keski-
Nisula et al. 2009, Hancox et al. 2013). 
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It has been hypothesized that the increased risk of asthma in children born by 
caesarean section may be due to differences in microbial exposures related to cae-
sarean section and vaginal delivery. The gut microbiota in children born by cae-
sarean section has been observed to differ from those of children born vaginally 
(Grönlund et al. 1999), and thus caesarean section may play a role in the devel-
opment of asthma and allergic diseases by affecting the establishment of a child's 
gut microbiota. Other explanations suggest that the association may be confound-
ed by the underlying indication for caesarean section or by some other factor or 
condition already present at or before birth (Bernsen et al. 2006, Almqvist and 
Rejnö 2013). Further, asthma in particular may be predisposed by respiratory 
problems identified in some newborns born by section (Levine et al. 2001). Alt-
hough children born by assisted vaginal delivery are exposed to maternal vaginal 
microbes, they may face respiratory problems due to asphyxia and its treatment 
and thus be at increased risk for developing asthma (Bernsen et al. 2006). In addi-
tion, the underlying indication for assisted vaginal delivery may also be the expla-
nation for this association (Almqvist and Rejnö 2013). Further, the age-dependent 
associations with the risk of asthma observed in the present study and the differ-
ences between previously published results are likely due to methodological 
and/or etiological factors. 
 
Twin or other multiple pregnancies 
In the present study, multiple pregnancy was associated with a decreased risk of 
CMA. This association has not been explored previously, and even the evidence 
regarding the risk of asthma in childhood among members of a multiple pregnancy 
is limited (Strachan et al. 2000, McKeever et al. 2001, Dik et al. 2004). Previous 
studies have observed a decreased risk of asthma among twins (Strachan et al. 
2000, McKeever et al. 2001, Dik et al. 2004), but the present study failed to find 
an association between multiple pregnancy and asthma.   
 
Complications during pregnancy 
Complications during pregnancy, neither in general nor any specific complication, 
were not associated with CMA or asthma in the present study. Previous studies on 
asthma have found an association between some specific complications or compli-
cations in general and an increased risk of asthma (Nafstad et al. 2000, Annesi-
Maesano et al. 2001, McKeever et al. 2002b, Nafstad et al. 2003, Dik et al. 2004), 
but no specific biological mechanism by which complications would affect the 
development of asthma has been suggested.   
 
Gestational age and child anthropometric measures 
None of the factors indicating restricted fetal growth or low gestational age were 
associated with CMA in the present study. However, an increased risk of CMA 
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was observed in children born with a high birth weight. No studies have previous-
ly reported an association between gestational age, a child's birth weight or birth 
length and the risk of CMA. A decreased risk of egg and any food allergy in low 
birth weight children has previously been reported (Hikino et al. 2001, Koplin et 
al. 2012). Liem and co-workers (2007) assessed the role of both low and high 
birth weight on the development of food allergy in childhood, but they did not 
observe any associations (Liem et al. 2007). Low birth weight and preterm birth 
have been associated with a decreased risk of atopy among young adults (Siltanen 
et al. 2011).  
Short gestational age was associated with an increased risk of asthma diag-
nosed at any age in the present study, which is in line the with majority of large, 
register-based cohort studies published previously (McKeever et al. 2002a, Yuan 
et al. 2003, Dik et al. 2004, Jaakkola and Gissler 2004, Bernsen et al. 2005, 
Gessner and Chimonas 2007, Dombkowski et al. 2008, Vogt et al. 2011), but not 
all of them (Yuan et al. 2002). The finding from the present study that low birth 
weight was associated with asthma diagnosed before the age of three years but not 
later is in line with results from studies by Davidson et al. (2010) and Bråbäck et 
al. (2003). 
The association between prematurity and an increased risk of asthma has been 
explained by the fact that prematurity causes reduced lung growth and reduced 
airway caliber, which may increase wheezing symptoms during respiratory infec-
tions which, in turn, may increase asthma diagnoses (Jaakkola et al. 2006). On the 
other hand, prematurity may predispose the child to respiratory tract infections, 
which could give a rise to wheezing symptoms often misleadingly diagnosed as 
asthma in early childhood. Low birth weight often results from low gestational 
age, but low birth weight can also indicate growth restriction in utero independent-
ly from gestational age. The exact mechanism behind fetal growth restriction and 
subsequent asthma development is not clear, and it has been suggested that, in-
stead of fetal growth restriction per se, the rapid catch-up growth following re-
stricted fetal growth would predispose for the development of asthma (Tedner et 
al. 2012). 
6.4 Use of antibiotics as risk factors for cow's milk allergy 
and asthma 
Determinants of antibiotic use 
Maternal asthma, smoking during pregnancy and a high number of previous deliv-
eries were associated with the maternal use of antibiotics during pregnancy in the 
present study. Further, high maternal age, a high number of maternal previous 
deliveries, maternal use of antibiotics and a child's male gender were associated 
with the child's use of antibiotics during early childhood. These associations and 
those identified in previous studies – such as parental educational level (Ciofli 
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Degli Atti et al. 2006, Mangrio et al. 2009), parental perceptions (Ciofli Degli Atti 
et al. 2006) and long-term illnesses (Louhi-Pirkanniemi et al. 2003, Harris et al. 
2007) – may reflect parental healthcare-seeking behaviour and thus affect the 
child's possibility of being taken to a physician and receiving a prescription foran-
tibiotics. Further, a high number of maternal previous deliveries, reflecting a high 
number of older siblings, may affect a child's use of antibiotics by increasing the 
risk for respiratory infections from siblings (Louhi-Pirkanniemi et al. 2003, Si-
moes 2003, Harris et al. 2007) and thus the child’s chance of receiving an antibi-
otic prescription. 
 
Maternal use of antibiotics 
An increased risk of CMA in children whose mothers had used antibiotics before 
and during pregnancy as observed in the present study has not been reported pre-
viously. On the other hand, the evidence on prenatal antibiotics and the risk of 
asthma is accumulating. Our observation that maternal use of antibiotics during 
pregnancy was associated with an increased risk of asthma is in line with results 
from other large cohort studies (McKeever et al. 2002b, Martel et al. 2009, Källén 
et al. 2013), but not with all previous studies (Calvani et al. 2004, Rusconi et al. 
2007, Dom et al. 2010). The inconsistency between results from previously pub-
lished studies is likely due to methodological issues such as differences in the 
asthma definition, the study designs and the study populations. Further, as in the 
present study, several putative confounding factors were considered in the previ-
ous studies, but maternal asthma, which may be associated with excess use of 
antibiotics, was considered only in half of the previous studies.  
Exposure to prenatal antibiotics has been suggested to affect the development 
of asthma in childhood via their adverse effect on human microbiota (Sullivan et 
al. 2001), namely maternal vaginal and gut microbiota. These disturbances in 
maternal microbiota may, in turn, influence the early colonization of child’s gut 
microbiota and further disturb the maturation of the child's immune system. As the 
adverse effects of antibiotics on human microbiota may last several months or 
even years (Sjölund et al. 2005, Jakobsson et al. 2007, Jakobsson et al. 2010), 
maternal antibiotics used before pregnancy may also influence the process of early 
colonization of child's gut microbiota. Evidence that different environmental ex-
posures during the prenatal period can modify gene expression and susceptibility 
to allergic diseases through epigenetic modification is accumulating, although the 
capacity of antibiotics to induce epigenetic changes in gene expression has not 
been demonstrated (Prescott and Clifton 2009). On the other hand, exposure to 
antibiotics could serve as a marker for infections, but the role of infections for 
which the antibiotics are prescribed in confounding the association between prena-
tal antibiotics and asthma in childhood has not received attention in previous stud-
ies. We investigated this issue of “confounding by indication” by grouping the 
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antibiotics by their indicated use, but we were not able to draw conclusions from 
this analysis due to lack of power. On the contrary, the issue of “confounding by 
indication” has been much debated regarding children’s own use of antibiotics and 
the development of asthma (see discussion later). 
 
Children’s use of antibiotics 
Associations between children’s use of antibiotics and the risk of CMA have not 
been published previously and thus further studies are needed on this topic.  
The finding of an increased risk of asthma in children who had used antibiotics 
during their first year of life is in line with results from several other large register-
based cohort studies (McKeever et al. 2002c, Kozyrskyj et al. 2007, Marra et al. 
2009, Martel et al. 2009), but not with all results reported previously (Table 4). 
The majority of previous studies on asthma had explored children's use of antibiot-
ics only during the first year of life (Table 4). When extending the children's expo-
sure period beyond the first year of life, we observed even stronger associations 
than previously reported. Harris and co-workers (2007) reported associations be-
tween total antibiotic counts yearly up to the age of five years and wheeze at eight 
years of age, but the associations were not substantially different between expo-
sure periods in the first year of life or the first five years of life. In accordance 
with previous studies, we observed stronger associations between children’s use of 
antibiotics and asthma among children diagnosed in early rather than later child-
hood (McKeever et al. 2002c, Marra et al. 2009, Martel et al. 2009). Further, three 
studies observed an increased risk of asthma at an earlier age, but not at a later age 
(Celedon et al. 2004, Mai et al. 2010, Almqvist et al. 2012b). We observed some 
variation in the strength of the associations between different specific antibiotics, 
with the strongest association observed for cephalosporins in the CMA population 
and for macrolides in the asthma population. Similarly, some variation in the asso-
ciations between specific antibiotics and asthma was reported in two other studies 
(McKeever et al. 2002c, Marra et al. 2009). 
Although results from cohort studies exploring the association between chil-
dren’s use of antibiotics and the risk of asthma are inconsistent, the findings from 
the present study are in line with those observed in studies most comparable to the 
present study in methodology. Thus, inconsistencies between results from other 
studies are likely due to differences in methodology: the null associations were 
reported mainly by studies that were retrospective in design, had rather small sam-
ple size and were relying on reported antibiotic use or asthma symptoms or drug 
use rather than confirmed asthma. Further, differences in practices for prescribing 
specific antibiotics between countries may explain inconsistent findings.  
As with prenatal antibiotics, exposure to antibiotics in early childhood may af-
fect the development of asthma and allergic diseases via their adverse effect on gut 
microbiota. Antibiotic-induced disturbances in a child's gut microbiota may inter-
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fere the early colonization of gut microbiota and further disturb the maturation of 
the immune system and development of tolerance towards oral and inhaled anti-
gens (Noverr and Huffnagle 2005). On the other hand, some authors have argued 
that much if not all of the reported associations between postnatal antibiotics and 
asthma, in particular, are accounted for respiratory infections for which the antibi-
otics have been prescribed for or reverse causality (Penders et al. 2011, Almqvist 
et al. 2012). However, the relationship between respiratory infections and the 
development of asthma remains controversial (Bartlett et al. 2009), and results 
pointing towards an independent association of antibiotics with the risk of asthma 
have been reported (McKeever et al. 2002c, Kozyrskyj et al. 2007, Marra et al. 
2009, Martel et al. 2009, Risnes et al. 2011). Moreover, a variety of social and 
clinical factors influence the prescribing of antibiotics, and the use of antibiotics is 
determined both by the infection and its symptoms and by the complex variations 
in healthcare-seeking behaviour (see discussion earlier). 
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7 Conclusions  
Based on the main findings of the present study, the following conclusions were 
drawn: 
 
• A high number of maternal previous deliveries were associated with a de-
creased risk of both CMA and asthma in the offspring. In addition, high ma-
ternal socioeconomic status, high maternal age and a child’s delivery by cae-
sarean section, as well as a child’s high birth weight were associated with an 
increased risk of CMA, while maternal smoking during pregnancy and multi-
ple pregnancy were associated with a decreased risk of CMA. In addition, ma-
ternal asthma and low gestational age were associated with an increased risk of 
asthma. 
 
• The maternal use of antibiotics both before and during pregnancy as well as 
the child use of antibiotics during early childhood were dose-dependently as-
sociated with an increased risk of both CMA and asthma.  
 
• A high number of maternal previous deliveries were directly associated with 
use of antibiotics among both control mothers and control children in the 
CMA and asthma populations. In addition, maternal asthma and smoking dur-
ing pregnancy were directly associated with the maternal use of antibiotics. 
Further, maternal age, previous miscarriages, child ponderal index or birth 
weight, male sex, and maternal use of antibiotics were directly associated with 
child use of antibiotics. 
 
These findings emphasise the important and complex role of prenatal and early 
childhood exposures in the development of CMA and asthma in childhood. Alt-
hough most maternal sociodemographic and perinatal factors included in the pre-
sent study are not easily modifiable and thus not practical to use in the prevention 
of asthma and other allergic diseases, identification of such factors may help focus 
preventive strategies on those children who are at high risk. 
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8 Future directions  
The results of the present study emphasise the need to fill the gap in the literature 
on the role of different environmental factors such as perinatal factors and the use 
of antibiotics in the development of CMA. Future research topics raised from the 
present study include  
 
• assessment of the role of different environmental factors, operating both pre- 
and postnatally, in the development of CMA in large cohort settings with sev-
eral possible confounding factors, such as parental allergies and infant feeding 
taken into account. 
 
• examination of the role of  antibiotics in the development of CMA in different 
populations and study settings and with several possible confounding factors 
taken into account. 
 
• examination of the causality of the association between maternal and childs 
use of antibiotics and the risk of asthma in large, prospective settings with fol-
low-up at least to school age and detailed information on antibiotic use and po-
tential confounding factors, e.g. indication for antibiotics, diet and healthcare-
seeking behaviour. 
 
• examination of the biological mechanisms behind the associations between 
maternal background, perinatal factors and the use of antibiotics and the de-
velopment of CMA and asthma. 
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APPENDIX 1 List of maternal background 
and perinatal factors and their 
categorization used in the present study 
Variable name Categorization Details of categorization 
Maternal age at delivery <25, 25–29, 30–34 and ≥35 years  
Maternal smoking during 
pregnancy 
no/yes yes category included those who quit smoking 
during the first trimester 
Maternal socioeconomic status upper white-collar workers 
lower white-collar workers 
blue-collar workers 
others 
information on occupation or education was 
converted into socioeconomic status and further 
aggregated into four groups 
"others" included students, housewives, farmers, 
entrepreneurs, unemployed and retired 
Previous miscarriages no/yes  
Previous deliveries 0, 1, 2, 3, 4, ≥5  
Multiple pregnancy no/yes based on information on number of fetuses 
Mode of delivery normal vaginal delivery 
assisted vaginal delivery 
planned caesarean section 
unplanned caesarean section 
 
Gestational age quartiles1  
quintiles2 
based on distribution of the controls 
Birth weight quartiles1  
quintiles2 
based on distribution of the controls 
Birth height quartiles1  
quintiles2 
based on distribution of the controls 
Ponderal index quartiles1  
quintiles2 
based on distribution of the controls 
Gestational age adjusted birth 
weight 
small-for-gestational age (SGA) 
average-for-gestational age (AGA) 
large-for gestational age (LGA) 
defined according to Finnish sex-specific 
population-based growth curves 
Prematurity no/yes yes = gestational age<37 weeks 
Low birth weight no/yes yes = birth weight <2,500 g 
Apgar score at 1 min 0–6, 7–8, 9–10  
High blood pressure no/yes yes = high blood pressure during pregnancy that 
had to be treated in hospital 
Abnormal presentation no/yes yes = breech and other abnormal presentation 
Placental complications no/yes yes = placenta previa and placenta avulsion 
Fetal asphyxia no/yes  
1 variable was used only in the asthma population 
2 variable was used only in the cow's milk allergy population 
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APPENDIX 2 List of variables and their 
categorization used to assess maternal 
and child use of antibiotics in the present 
study 
Exposure 
period 
Variable name Categorization 
(number of 
purchases) 
 
 
 
 
 
 
Before 
pregnancy 
Maternal use  
Overall use of any antibiotic  0 vs ≥1 
Overall use of cephalosporins  0 vs ≥1 
Overall use of penicillins with extended spectrum  0 vs ≥1 
Overall use of macrolides  0 vs ≥1 
Overall use of tetracyclines  0 vs ≥1 
Overall use of phenoxymethyl penicillin  0 vs ≥1 
Overall use of sulphonamides and trimetoprim  0 vs ≥1 
Overall use of fluoroquinolones  0 vs ≥1 
Number of purchases or any antibiotics  0 vs. 1, 2, ≥3 
   
 
 
 
 
 
 
 
 
During 
pregnancy 
Overall use of any antibiotic  0 vs ≥1 
Overall use of cephalosporins  0 vs ≥1 
Overall use of penicillins with extended spectrum  0 vs ≥1 
Overall use of macrolides  0 vs ≥1 
Overall use of tetracyclines  0 vs ≥1 
Overall use of phenoxymethyl penicillin  0 vs ≥1 
Overall use of sulphonamides and trimetoprim  0 vs ≥1 
Overall use of fluoroquinolones  0 vs ≥1 
Number of purchases of any antibiotics  0 vs. 1, 2, ≥3 
Overall use of only those antibiotics commonly used to treat respiratory tract 
infections (penicillins with extended spectrum, macrolides, cephalosporins 
and phenoxymethylpenicillin)2 
0 vs ≥1 
Overall use of only those antibiotics commonly used to treat urinary tract 
infections (trimethoprim, its combinations with sulphonamides and 
fluoroquinolones)2 
0 vs ≥1 
Overall use of both of those antibiotics commonly used to treat respiratory 
tract infections and urinary tract infections2 
0 vs ≥1 
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Appendix 2 (Continued) 
 
 
 
 
 
 
 
 
 
During the 
first year of 
life 
Child's use  
Overall use of any antibiotics1 0 vs ≥1 
Overall use of amoxicillin1 0 vs ≥1 
Overall use of macrolides1 0 vs ≥1 
Overall use of cephalosporins1 0 vs ≥1 
Overall use of sulphonamides and trimetoprim1 0 vs ≥1 
Overall use of phenoxymethyl penicillin1 0 vs ≥1 
Overall use of only those antibiotics commonly used to treat respiratory tract 
infections (amoxicillin, macrolides, cephalosporins and 
phenoxymethylpenicillin)2 
0 vs ≥1 
Overall use of only those antibiotics commonly used to treat urinary tract 
infections (trimethoprim and its combinations with sulphonamides)2 
0 vs ≥1 
Overall use of both of those antibiotics commonly used to treat respiratory 
tract infections and urinary tract infections2 
0 vs ≥1 
Number of purchases of any antibiotics1 0 vs. 1, 2, 3, 4, ≥5 
   
 
 
 
 
 
 
 
 
 
 
From birth 
to 
diagnosis 
Overall use of any antibiotics  0 vs ≥1 
Overall use of amoxicillin  0 vs ≥1 
Overall use of macrolides  0 vs ≥1 
Overall use of cephalosporins  0 vs ≥1 
Overall use of sulphonamides and trimetoprim  0 vs ≥1 
Overall use of phenoxymethyl penicillin  0 vs ≥1 
Overall use of only those antibiotics commonly used to treat respiratory tract 
infections (amoxicillin, macrolides, cephalosporins and 
phenoxymethylpenicillin)2 
0 vs ≥1 
Overall use of only those antibiotics commonly used to treat urinary tract 
infections (trimethoprim and its combinations with sulphonamides)2 
0 vs ≥1 
Overall use of both of those antibiotics commonly used to treat respiratory 
tract infections and urinary tract infections2 
0 vs ≥1 
Number of purchases of any antibiotics  0 vs. 1, 2, 3, 4, ≥5 
Number of purchases of any antibiotics1 0 vs. 1, 2, 3, 4, 5, 
6-7, 8-9, ≥10 
   
During the 
first 3 years 
of life 
Frequent use of any antibiotics among controls1 0-5 vs. ≥6 
1 variable was used only in the asthma population 
2 variable used only among children with asthma diagnosed at the age of 3 years or later 
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